{
  "cells": [
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "xrtLuqFLKywG",
        "outputId": "58df5d72-636e-4e83-cdb1-47967f48f9a3"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Collecting langchain\n",
            "  Downloading langchain-0.2.3-py3-none-any.whl (974 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m974.0/974.0 kB\u001b[0m \u001b[31m11.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: PyYAML>=5.3 in /usr/local/lib/python3.10/dist-packages (from langchain) (6.0.1)\n",
            "Requirement already satisfied: SQLAlchemy<3,>=1.4 in /usr/local/lib/python3.10/dist-packages (from langchain) (2.0.30)\n",
            "Requirement already satisfied: aiohttp<4.0.0,>=3.8.3 in /usr/local/lib/python3.10/dist-packages (from langchain) (3.9.5)\n",
            "Requirement already satisfied: async-timeout<5.0.0,>=4.0.0 in /usr/local/lib/python3.10/dist-packages (from langchain) (4.0.3)\n",
            "Collecting langchain-core<0.3.0,>=0.2.0 (from langchain)\n",
            "  Downloading langchain_core-0.2.5-py3-none-any.whl (314 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m314.7/314.7 kB\u001b[0m \u001b[31m29.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hCollecting langchain-text-splitters<0.3.0,>=0.2.0 (from langchain)\n",
            "  Downloading langchain_text_splitters-0.2.1-py3-none-any.whl (23 kB)\n",
            "Collecting langsmith<0.2.0,>=0.1.17 (from langchain)\n",
            "  Downloading langsmith-0.1.77-py3-none-any.whl (125 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m125.2/125.2 kB\u001b[0m \u001b[31m13.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: numpy<2,>=1 in /usr/local/lib/python3.10/dist-packages (from langchain) (1.25.2)\n",
            "Requirement already satisfied: pydantic<3,>=1 in /usr/local/lib/python3.10/dist-packages (from langchain) (2.7.3)\n",
            "Requirement already satisfied: requests<3,>=2 in /usr/local/lib/python3.10/dist-packages (from langchain) (2.31.0)\n",
            "Requirement already satisfied: tenacity<9.0.0,>=8.1.0 in /usr/local/lib/python3.10/dist-packages (from langchain) (8.3.0)\n",
            "Requirement already satisfied: aiosignal>=1.1.2 in /usr/local/lib/python3.10/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain) (1.3.1)\n",
            "Requirement already satisfied: attrs>=17.3.0 in /usr/local/lib/python3.10/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain) (23.2.0)\n",
            "Requirement already satisfied: frozenlist>=1.1.1 in /usr/local/lib/python3.10/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain) (1.4.1)\n",
            "Requirement already satisfied: multidict<7.0,>=4.5 in /usr/local/lib/python3.10/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain) (6.0.5)\n",
            "Requirement already satisfied: yarl<2.0,>=1.0 in /usr/local/lib/python3.10/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain) (1.9.4)\n",
            "Collecting jsonpatch<2.0,>=1.33 (from langchain-core<0.3.0,>=0.2.0->langchain)\n",
            "  Downloading jsonpatch-1.33-py2.py3-none-any.whl (12 kB)\n",
            "Collecting packaging<24.0,>=23.2 (from langchain-core<0.3.0,>=0.2.0->langchain)\n",
            "  Downloading packaging-23.2-py3-none-any.whl (53 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m53.0/53.0 kB\u001b[0m \u001b[31m5.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hCollecting orjson<4.0.0,>=3.9.14 (from langsmith<0.2.0,>=0.1.17->langchain)\n",
            "  Downloading orjson-3.10.4-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (142 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m142.7/142.7 kB\u001b[0m \u001b[31m13.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: annotated-types>=0.4.0 in /usr/local/lib/python3.10/dist-packages (from pydantic<3,>=1->langchain) (0.7.0)\n",
            "Requirement already satisfied: pydantic-core==2.18.4 in /usr/local/lib/python3.10/dist-packages (from pydantic<3,>=1->langchain) (2.18.4)\n",
            "Requirement already satisfied: typing-extensions>=4.6.1 in /usr/local/lib/python3.10/dist-packages (from pydantic<3,>=1->langchain) (4.12.2)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests<3,>=2->langchain) (3.3.2)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests<3,>=2->langchain) (3.7)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests<3,>=2->langchain) (2.0.7)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests<3,>=2->langchain) (2024.6.2)\n",
            "Requirement already satisfied: greenlet!=0.4.17 in /usr/local/lib/python3.10/dist-packages (from SQLAlchemy<3,>=1.4->langchain) (3.0.3)\n",
            "Collecting jsonpointer>=1.9 (from jsonpatch<2.0,>=1.33->langchain-core<0.3.0,>=0.2.0->langchain)\n",
            "  Downloading jsonpointer-3.0.0-py2.py3-none-any.whl (7.6 kB)\n",
            "Installing collected packages: packaging, orjson, jsonpointer, jsonpatch, langsmith, langchain-core, langchain-text-splitters, langchain\n",
            "  Attempting uninstall: packaging\n",
            "    Found existing installation: packaging 24.1\n",
            "    Uninstalling packaging-24.1:\n",
            "      Successfully uninstalled packaging-24.1\n",
            "Successfully installed jsonpatch-1.33 jsonpointer-3.0.0 langchain-0.2.3 langchain-core-0.2.5 langchain-text-splitters-0.2.1 langsmith-0.1.77 orjson-3.10.4 packaging-23.2\n"
          ]
        }
      ],
      "source": [
        "pip install langchain"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Alk93MInY5ME",
        "outputId": "f4b72f39-2a8c-48ee-debb-86d571ba386c"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Collecting langchain_openai\n",
            "  Downloading langchain_openai-0.1.8-py3-none-any.whl (38 kB)\n",
            "Requirement already satisfied: langchain-core<0.3,>=0.2.2 in /usr/local/lib/python3.10/dist-packages (from langchain_openai) (0.2.5)\n",
            "Collecting openai<2.0.0,>=1.26.0 (from langchain_openai)\n",
            "  Downloading openai-1.34.0-py3-none-any.whl (325 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m325.5/325.5 kB\u001b[0m \u001b[31m4.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hCollecting tiktoken<1,>=0.7 (from langchain_openai)\n",
            "  Downloading tiktoken-0.7.0-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (1.1 MB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m1.1/1.1 MB\u001b[0m \u001b[31m7.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: PyYAML>=5.3 in /usr/local/lib/python3.10/dist-packages (from langchain-core<0.3,>=0.2.2->langchain_openai) (6.0.1)\n",
            "Requirement already satisfied: jsonpatch<2.0,>=1.33 in /usr/local/lib/python3.10/dist-packages (from langchain-core<0.3,>=0.2.2->langchain_openai) (1.33)\n",
            "Requirement already satisfied: langsmith<0.2.0,>=0.1.66 in /usr/local/lib/python3.10/dist-packages (from langchain-core<0.3,>=0.2.2->langchain_openai) (0.1.77)\n",
            "Requirement already satisfied: packaging<24.0,>=23.2 in /usr/local/lib/python3.10/dist-packages (from langchain-core<0.3,>=0.2.2->langchain_openai) (23.2)\n",
            "Requirement already satisfied: pydantic<3,>=1 in /usr/local/lib/python3.10/dist-packages (from langchain-core<0.3,>=0.2.2->langchain_openai) (2.7.3)\n",
            "Requirement already satisfied: tenacity<9.0.0,>=8.1.0 in /usr/local/lib/python3.10/dist-packages (from langchain-core<0.3,>=0.2.2->langchain_openai) (8.3.0)\n",
            "Requirement already satisfied: anyio<5,>=3.5.0 in /usr/local/lib/python3.10/dist-packages (from openai<2.0.0,>=1.26.0->langchain_openai) (3.7.1)\n",
            "Requirement already satisfied: distro<2,>=1.7.0 in /usr/lib/python3/dist-packages (from openai<2.0.0,>=1.26.0->langchain_openai) (1.7.0)\n",
            "Collecting httpx<1,>=0.23.0 (from openai<2.0.0,>=1.26.0->langchain_openai)\n",
            "  Downloading httpx-0.27.0-py3-none-any.whl (75 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m75.6/75.6 kB\u001b[0m \u001b[31m8.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: sniffio in /usr/local/lib/python3.10/dist-packages (from openai<2.0.0,>=1.26.0->langchain_openai) (1.3.1)\n",
            "Requirement already satisfied: tqdm>4 in /usr/local/lib/python3.10/dist-packages (from openai<2.0.0,>=1.26.0->langchain_openai) (4.66.4)\n",
            "Requirement already satisfied: typing-extensions<5,>=4.7 in /usr/local/lib/python3.10/dist-packages (from openai<2.0.0,>=1.26.0->langchain_openai) (4.12.2)\n",
            "Requirement already satisfied: regex>=2022.1.18 in /usr/local/lib/python3.10/dist-packages (from tiktoken<1,>=0.7->langchain_openai) (2024.5.15)\n",
            "Requirement already satisfied: requests>=2.26.0 in /usr/local/lib/python3.10/dist-packages (from tiktoken<1,>=0.7->langchain_openai) (2.31.0)\n",
            "Requirement already satisfied: idna>=2.8 in /usr/local/lib/python3.10/dist-packages (from anyio<5,>=3.5.0->openai<2.0.0,>=1.26.0->langchain_openai) (3.7)\n",
            "Requirement already satisfied: exceptiongroup in /usr/local/lib/python3.10/dist-packages (from anyio<5,>=3.5.0->openai<2.0.0,>=1.26.0->langchain_openai) (1.2.1)\n",
            "Requirement already satisfied: certifi in /usr/local/lib/python3.10/dist-packages (from httpx<1,>=0.23.0->openai<2.0.0,>=1.26.0->langchain_openai) (2024.6.2)\n",
            "Collecting httpcore==1.* (from httpx<1,>=0.23.0->openai<2.0.0,>=1.26.0->langchain_openai)\n",
            "  Downloading httpcore-1.0.5-py3-none-any.whl (77 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m77.9/77.9 kB\u001b[0m \u001b[31m7.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hCollecting h11<0.15,>=0.13 (from httpcore==1.*->httpx<1,>=0.23.0->openai<2.0.0,>=1.26.0->langchain_openai)\n",
            "  Downloading h11-0.14.0-py3-none-any.whl (58 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m58.3/58.3 kB\u001b[0m \u001b[31m5.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: jsonpointer>=1.9 in /usr/local/lib/python3.10/dist-packages (from jsonpatch<2.0,>=1.33->langchain-core<0.3,>=0.2.2->langchain_openai) (3.0.0)\n",
            "Requirement already satisfied: orjson<4.0.0,>=3.9.14 in /usr/local/lib/python3.10/dist-packages (from langsmith<0.2.0,>=0.1.66->langchain-core<0.3,>=0.2.2->langchain_openai) (3.10.4)\n",
            "Requirement already satisfied: annotated-types>=0.4.0 in /usr/local/lib/python3.10/dist-packages (from pydantic<3,>=1->langchain-core<0.3,>=0.2.2->langchain_openai) (0.7.0)\n",
            "Requirement already satisfied: pydantic-core==2.18.4 in /usr/local/lib/python3.10/dist-packages (from pydantic<3,>=1->langchain-core<0.3,>=0.2.2->langchain_openai) (2.18.4)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests>=2.26.0->tiktoken<1,>=0.7->langchain_openai) (3.3.2)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests>=2.26.0->tiktoken<1,>=0.7->langchain_openai) (2.0.7)\n",
            "Installing collected packages: h11, tiktoken, httpcore, httpx, openai, langchain_openai\n",
            "Successfully installed h11-0.14.0 httpcore-1.0.5 httpx-0.27.0 langchain_openai-0.1.8 openai-1.34.0 tiktoken-0.7.0\n"
          ]
        }
      ],
      "source": [
        "pip install langchain_openai"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "8z93yg5FZOmb",
        "outputId": "32bbdf8b-2efb-4612-9be5-5c844c759fdc"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Collecting langchain_community\n",
            "  Downloading langchain_community-0.2.4-py3-none-any.whl (2.2 MB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.2/2.2 MB\u001b[0m \u001b[31m8.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: PyYAML>=5.3 in /usr/local/lib/python3.10/dist-packages (from langchain_community) (6.0.1)\n",
            "Requirement already satisfied: SQLAlchemy<3,>=1.4 in /usr/local/lib/python3.10/dist-packages (from langchain_community) (2.0.30)\n",
            "Requirement already satisfied: aiohttp<4.0.0,>=3.8.3 in /usr/local/lib/python3.10/dist-packages (from langchain_community) (3.9.5)\n",
            "Collecting dataclasses-json<0.7,>=0.5.7 (from langchain_community)\n",
            "  Downloading dataclasses_json-0.6.7-py3-none-any.whl (28 kB)\n",
            "Requirement already satisfied: langchain<0.3.0,>=0.2.0 in /usr/local/lib/python3.10/dist-packages (from langchain_community) (0.2.3)\n",
            "Requirement already satisfied: langchain-core<0.3.0,>=0.2.0 in /usr/local/lib/python3.10/dist-packages (from langchain_community) (0.2.5)\n",
            "Requirement already satisfied: langsmith<0.2.0,>=0.1.0 in /usr/local/lib/python3.10/dist-packages (from langchain_community) (0.1.77)\n",
            "Requirement already satisfied: numpy<2,>=1 in /usr/local/lib/python3.10/dist-packages (from langchain_community) (1.25.2)\n",
            "Requirement already satisfied: requests<3,>=2 in /usr/local/lib/python3.10/dist-packages (from langchain_community) (2.31.0)\n",
            "Requirement already satisfied: tenacity<9.0.0,>=8.1.0 in /usr/local/lib/python3.10/dist-packages (from langchain_community) (8.3.0)\n",
            "Requirement already satisfied: aiosignal>=1.1.2 in /usr/local/lib/python3.10/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (1.3.1)\n",
            "Requirement already satisfied: attrs>=17.3.0 in /usr/local/lib/python3.10/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (23.2.0)\n",
            "Requirement already satisfied: frozenlist>=1.1.1 in /usr/local/lib/python3.10/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (1.4.1)\n",
            "Requirement already satisfied: multidict<7.0,>=4.5 in /usr/local/lib/python3.10/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (6.0.5)\n",
            "Requirement already satisfied: yarl<2.0,>=1.0 in /usr/local/lib/python3.10/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (1.9.4)\n",
            "Requirement already satisfied: async-timeout<5.0,>=4.0 in /usr/local/lib/python3.10/dist-packages (from aiohttp<4.0.0,>=3.8.3->langchain_community) (4.0.3)\n",
            "Collecting marshmallow<4.0.0,>=3.18.0 (from dataclasses-json<0.7,>=0.5.7->langchain_community)\n",
            "  Downloading marshmallow-3.21.3-py3-none-any.whl (49 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m49.2/49.2 kB\u001b[0m \u001b[31m5.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hCollecting typing-inspect<1,>=0.4.0 (from dataclasses-json<0.7,>=0.5.7->langchain_community)\n",
            "  Downloading typing_inspect-0.9.0-py3-none-any.whl (8.8 kB)\n",
            "Requirement already satisfied: langchain-text-splitters<0.3.0,>=0.2.0 in /usr/local/lib/python3.10/dist-packages (from langchain<0.3.0,>=0.2.0->langchain_community) (0.2.1)\n",
            "Requirement already satisfied: pydantic<3,>=1 in /usr/local/lib/python3.10/dist-packages (from langchain<0.3.0,>=0.2.0->langchain_community) (2.7.3)\n",
            "Requirement already satisfied: jsonpatch<2.0,>=1.33 in /usr/local/lib/python3.10/dist-packages (from langchain-core<0.3.0,>=0.2.0->langchain_community) (1.33)\n",
            "Requirement already satisfied: packaging<24.0,>=23.2 in /usr/local/lib/python3.10/dist-packages (from langchain-core<0.3.0,>=0.2.0->langchain_community) (23.2)\n",
            "Requirement already satisfied: orjson<4.0.0,>=3.9.14 in /usr/local/lib/python3.10/dist-packages (from langsmith<0.2.0,>=0.1.0->langchain_community) (3.10.4)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests<3,>=2->langchain_community) (3.3.2)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests<3,>=2->langchain_community) (3.7)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests<3,>=2->langchain_community) (2.0.7)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests<3,>=2->langchain_community) (2024.6.2)\n",
            "Requirement already satisfied: typing-extensions>=4.6.0 in /usr/local/lib/python3.10/dist-packages (from SQLAlchemy<3,>=1.4->langchain_community) (4.12.2)\n",
            "Requirement already satisfied: greenlet!=0.4.17 in /usr/local/lib/python3.10/dist-packages (from SQLAlchemy<3,>=1.4->langchain_community) (3.0.3)\n",
            "Requirement already satisfied: jsonpointer>=1.9 in /usr/local/lib/python3.10/dist-packages (from jsonpatch<2.0,>=1.33->langchain-core<0.3.0,>=0.2.0->langchain_community) (3.0.0)\n",
            "Requirement already satisfied: annotated-types>=0.4.0 in /usr/local/lib/python3.10/dist-packages (from pydantic<3,>=1->langchain<0.3.0,>=0.2.0->langchain_community) (0.7.0)\n",
            "Requirement already satisfied: pydantic-core==2.18.4 in /usr/local/lib/python3.10/dist-packages (from pydantic<3,>=1->langchain<0.3.0,>=0.2.0->langchain_community) (2.18.4)\n",
            "Collecting mypy-extensions>=0.3.0 (from typing-inspect<1,>=0.4.0->dataclasses-json<0.7,>=0.5.7->langchain_community)\n",
            "  Downloading mypy_extensions-1.0.0-py3-none-any.whl (4.7 kB)\n",
            "Installing collected packages: mypy-extensions, marshmallow, typing-inspect, dataclasses-json, langchain_community\n",
            "Successfully installed dataclasses-json-0.6.7 langchain_community-0.2.4 marshmallow-3.21.3 mypy-extensions-1.0.0 typing-inspect-0.9.0\n"
          ]
        }
      ],
      "source": [
        "pip install langchain_community"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "7yDM7Wi_vQAO"
      },
      "source": [
        "#Không chạy all cell này"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "jeWnkga8LJp1"
      },
      "outputs": [],
      "source": [
        "def changing(refs,objects):\n",
        "  matched = [0]*len(refs)\n",
        "  add_in = \"\"\n",
        "  elemenate = \"\"\n",
        "  if refs == ['Do not have drug']\n",
        "  for i in range(len(objects)):\n",
        "    flag = 0\n",
        "    for j in range(len(refs)):\n",
        "      if objects[i] == refs[j]:\n",
        "        matched[j] = 1\n",
        "        flag = 1\n",
        "    if flag == 0:\n",
        "      add_in += objects[i] + \", \"\n",
        "  for k in range(len(matched)):\n",
        "    if matched[k] == 0:\n",
        "      elemenate += refs[k] + \", \"\n",
        "  return add_in,elemenate #text\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "lvp5gdHnpI8A"
      },
      "outputs": [],
      "source": [
        "#Full EHR\n",
        "import json\n",
        "# load file json - 1000 patients\n",
        "file = open('/content/drive/MyDrive/NLP/2024-05-VĨNHTHÀNH (1).json')\n",
        "data = json.load(file)\n",
        "patient_data = data\n",
        "k = patient_data.get('encounter',[])\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "gFJX_1jJK1CS"
      },
      "outputs": [],
      "source": [
        "#Full EHR\n",
        "import json\n",
        "# load file json - 1000 patients\n",
        "file = open('/content/drive/MyDrive/NLP/2024-05-VĨNHTHÀNH (1).json')\n",
        "data = json.load(file)\n",
        "med_info = []\n",
        "enc_timeline = []\n",
        "patient_data = data\n",
        "context = \"\"\n",
        "\n",
        "vital_sign = []\n",
        "date_enc = []\n",
        "Drug = []\n",
        "Diagnosis = []\n",
        "Note = []\n",
        "labtests = []\n",
        "clinical_exam = []\n",
        "diags = []\n",
        "Generic_drugs = {}\n",
        "\n",
        "count = 0\n",
        "k = patient_data.get('encounter',[])\n",
        "k = k[-1::-1]\n",
        "for pa_enc in k:\n",
        "  vital = \"\"\n",
        "  Drug_s = []\n",
        "  Diagnosis_s = []\n",
        "  if pa_enc is not None and int(pa_enc['performedDate'][-4:]) >= 2010: #Đặt điều kiện do biết trước\n",
        "    context += \"***\" + \"\\n\"\n",
        "    context += \"Bệnh nhân nam, 68 tuổi, nhóm máu B_RH+\" + \"\\n\"\n",
        "    context += \"Khám ngày \" + pa_enc['performedDate'] + \"\\n\"\n",
        "    try:\n",
        "      vital += \"pulse: \" + str(pa_enc['vitalSigns']['pulse']) + \"\\n\"\n",
        "      vital += \"bloodPressureLow: \" + str(pa_enc['vitalSigns']['bloodPressureLow']) + \"\\n\"\n",
        "      vital += \"bloodPressureHigh: \" + str(pa_enc['vitalSigns']['bloodPressureHigh']) + \"\\n\"\n",
        "      vital += \"respirationRate: \" + str(pa_enc['vitalSigns']['respirationRate']) + \"\\n\"\n",
        "    except:\n",
        "      pass\n",
        "    vital_sign.append(vital)\n",
        "    date_enc.append(pa_enc['performedDate'])\n",
        "  else:\n",
        "    continue\n",
        "  try:\n",
        "    name = [i for i in pa_enc['clinicalExamination'].keys()][0]\n",
        "    context += \"Khám: \" + [i for i in pa_enc['clinicalExamination'].keys()][0] + \"\\n\"\n",
        "    try:\n",
        "      clinical_exam.append(pa_enc['clinicalExamination'][name][\"vi\"])\n",
        "      context += \"clinical: \"+ pa_enc['clinicalExamination'][name][\"vi\"] +\"\\n\"\n",
        "    except:\n",
        "      clinical_exam.append(\"\")\n",
        "      context += \"clinical: \\n\"\n",
        "  except:\n",
        "    clinical_exam.append(\"\")\n",
        "  for pa_diag in pa_enc.get('diagnosis',{}).get('conclusion',[]):\n",
        "    diags.append(pa_diag['code']['text']['vi'] + \" \" + pa_diag['status']['text']['vi'])\n",
        "    #Diagnosis_s.append(pa_diag['code']['text']['vi'])\n",
        "  try:\n",
        "    context += pa_enc['diagnosis']['note']['vi'] + \"\\n\"\n",
        "    Note.append(pa_enc['diagnosis']['note']['vi'])\n",
        "  except:\n",
        "    Note.append(\"\")\n",
        "  for pa_med in pa_enc.get('medication',[]):\n",
        "    context += \"Thuốc: \" +pa_med['code']['text']['vi'] + \"\\n\"\n",
        "    Drug_s.append(pa_med['code']['text']['vi'])\n",
        "    try:\n",
        "      Generic_drugs[pa_med['code']['text']['vi']][count] = 1\n",
        "    except:\n",
        "      l = [0]*25\n",
        "      l[count] = 1\n",
        "      Generic_drugs[pa_med['code']['text']['vi']] = l\n",
        "  labtest = \"\"\n",
        "  for pa_lab in pa_enc.get('labResult',[]):\n",
        "    for pa_test in pa_lab.get('tests',[]):\n",
        "      context += \"Lab test:\" + pa_test['testCode']['text']['vi'] + \": \"\n",
        "      labtest += \"Lab test:\" + pa_test['testCode']['text']['vi'] + \": \"\n",
        "      try:\n",
        "        pa_test['valueQuantity']['value']\n",
        "        try:\n",
        "          context += str(pa_test['valueQuantity']['value']) +\" \"+ str(pa_test['range']) + \"\\n\"\n",
        "          labtest += str(pa_test['valueQuantity']['value']) +\" \"+ str(pa_test['range']) + \"\\n\"\n",
        "        except:\n",
        "          context += str(pa_test['valueQuantity']['value'])  + \"\\n\"\n",
        "          labtest += str(pa_test['valueQuantity']['value'])  + \"\\n\"\n",
        "      except:\n",
        "        try:\n",
        "          context += pa_test['valueString'] + \"\\n\"\n",
        "          labtest += pa_test['valueString'] + \"\\n\"\n",
        "        except:\n",
        "          pass\n",
        "\n",
        "  labtests.append(labtest)\n",
        "  if count == 0:\n",
        "    Drug_0 = Drug_s\n",
        "    Diagnosis_0 = Diagnosis_s\n",
        "    Drug.append(Drug_s)\n",
        "    Diagnosis.append(Diagnosis_s)\n",
        "  else:\n",
        "    add_drug,dele_drug = changing(Drug_0,Drug_s)\n",
        "    if add_drug == \"\" and dele_drug == \"\":\n",
        "      Drug.append([\"\"])\n",
        "    else:\n",
        "      Drug.append([\"Thêm: \"+ add_drug + \"\\n\" + \"Bỏ: \"+ dele_drug])\n",
        "    add_diag,dele_diag = changing(Diagnosis_0,Diagnosis_s)\n",
        "    if add_diag == \"\" and dele_diag == \"\":\n",
        "      Diagnosis.append([\"\"])\n",
        "    else:\n",
        "      Diagnosis.append([\"Thêm: \"+ add_diag + \"\\n\" + \"Bỏ: \"+ dele_diag])\n",
        "    Drug_0 = Drug_s\n",
        "    Diagnosis_0 = Diagnosis_s\n",
        "  count += 1\n",
        "  enc_timeline.append(context)\n",
        "  context = \"\"\n",
        "med_info.append(enc_timeline[-1::-1])\n",
        "enc_timeline = []"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "pBwfqAb5V_0-"
      },
      "outputs": [],
      "source": [
        "#Check for changing diagnose and drugs over time\n",
        "event = [0]*len(date_enc)\n",
        "for i in range(len(Drug)):\n",
        "  text = \".\".join(Drug[i])\n",
        "  if event[i] == 0:\n",
        "    event[i] = \"***\\n\"\n",
        "    event[i] += \"Khám ngày: \" + date_enc[i] + \"\\n\"\n",
        "    event[i] += \"Khám lâm sàng: \" + clinical_exam[i] + \"\\n\"\n",
        "    event[i] += \"Chẩn đoán: \" + \"\\n\"+ \",\".join(Diagnosis[i]) + \"\\n\"\n",
        "    event[i] += \"Thuốc: \" + text + \"\\n\"\n",
        "    event[i] += \"Note: \" + Note[i] + \"\\n\"\n",
        "    event[i] += \"Vital sign: \" + \"\\n\" + vital_sign[i]\n",
        "    event[i] += \"Xét nghiệm cận lâm sàn:\" + \"\\n\" + labtests[i]\n",
        "  else:\n",
        "    event[i] += \"Thuốc: \" + text + \"\\n\"\n",
        "    event[i] += \"Khám lâm sàng: \" + clinical_exam[i] + \"\\n\"\n",
        "    event[i] += \"Chẩn đoán: \" + \",\".join(Diagnosis[i]) + \"\\n\"\n",
        "    event[i] += \"Note: \" + Note[i] + \"\\n\"\n",
        "    event[i] += \"Vital sign: \" + \"\\n\" + vital_sign\n",
        "    event[i] += \"Xét nghiệm cận lâm sàn:\" + \"\\n\" + labtests[i]"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "pQwhRxp4qJIl"
      },
      "outputs": [],
      "source": [
        "import json\n",
        "#Get all diagnosis\n",
        "# load file json - 1000 patients\n",
        "file = open('/content/drive/MyDrive/NLP/data_ehr/2024-05-MAIHỮUPHƯỚC.json')\n",
        "data = json.load(file)\n",
        "all_diag = []\n",
        "patient_data = data\n",
        "k = patient_data.get('encounter',[])\n",
        "k = k[-1::-1]\n",
        "for pa_enc in k:\n",
        "  try:\n",
        "    for pa_diag in pa_enc.get('diagnosis',{}).get('conclusion',[]):\n",
        "      if pa_diag['code']['text']['vi'] not in all_diag:\n",
        "        all_diag.append(pa_diag['code']['text']['vi'])\n",
        "  except:\n",
        "    pass"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Cs4BbjQkw0a4"
      },
      "outputs": [],
      "source": [
        "all_diag_text = \"\"\n",
        "for i in all_diag:\n",
        "  all_diag_text += i + \"\\n\""
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "fu5hC_SE_-1c"
      },
      "outputs": [],
      "source": [
        "import json\n",
        "#Get all context enc\n",
        "file = open('/content/drive/MyDrive/NLP/data_ehr/2024-05-MAIHỮUPHƯỚC.json')\n",
        "data = json.load(file)\n",
        "patient_data = data\n",
        "\n",
        "vital_sign = []\n",
        "date_enc = []\n",
        "Drug = []\n",
        "Diagnosis = []\n",
        "Note = []\n",
        "labtests = []\n",
        "clinical_exam = []\n",
        "groups = []\n",
        "\n",
        "for pa_enc in k:\n",
        "  vital = \"\"\n",
        "  if pa_enc is not None:\n",
        "    try:\n",
        "      vital += \"pulse: \" + str(pa_enc['vitalSigns']['pulse']) + \"\\n\"\n",
        "      vital += \"bloodPressureLow: \" + str(pa_enc['vitalSigns']['bloodPressureLow']) + \"\\n\"\n",
        "      vital += \"bloodPressureHigh: \" + str(pa_enc['vitalSigns']['bloodPressureHigh']) + \"\\n\"\n",
        "      vital += \"respirationRate: \" + str(pa_enc['vitalSigns']['respirationRate']) + \"\\n\"\n",
        "    except:\n",
        "      pass\n",
        "    vital_sign.append(vital)\n",
        "    date_enc.append(pa_enc['performedDate'])\n",
        "  else:\n",
        "    continue\n",
        "  try:\n",
        "    name = [i for i in pa_enc['clinicalExamination'].keys()][0]\n",
        "    try:\n",
        "      clinical_exam.append(pa_enc['clinicalExamination'][name][\"vi\"])\n",
        "    except:\n",
        "      clinical_exam.append(\"\")\n",
        "  except:\n",
        "    clinical_exam.append(\"\")\n",
        "  set_group = []\n",
        "  diag_enc = {}\n",
        "  for pa_diag in pa_enc.get('diagnosis',{}).get('conclusion',[]):\n",
        "    diag_name = pa_diag['code']['text']['vi']\n",
        "    #diag_enc.append(diag_name + \" \" + pa_diag['status']['text']['vi'] + \"\\n\")\n",
        "    for group in context_event[0].format.keys():\n",
        "      if diag_name in context_event[0].format[group]:\n",
        "        set_group.append(group)\n",
        "        try:\n",
        "          if diag_name not in diag_enc[group]:\n",
        "            diag_enc[group].append(diag_name)\n",
        "        except:\n",
        "          diag_enc[group] = [diag_name]\n",
        "        break\n",
        "\n",
        "  set_group = list(set(set_group))\n",
        "  groups.append(set_group)\n",
        "  Diagnosis.append(diag_enc)\n",
        "  try:\n",
        "    Note.append(pa_enc['diagnosis']['note']['vi'])\n",
        "  except:\n",
        "    Note.append(\"\")\n",
        "  drug_enc = []\n",
        "  for pa_med in pa_enc.get('medication',[]):\n",
        "    drug_enc.append(pa_med['code']['text']['vi'])\n",
        "  drug_enc = list(set(drug_enc))\n",
        "  Drug.append(drug_enc)\n",
        "  labtest = \"\"\n",
        "  for pa_lab in pa_enc.get('labResult',[]):\n",
        "    for pa_test in pa_lab.get('tests',[]):\n",
        "      labtest += \"Lab test:\" + pa_test['testCode']['text']['vi'] + \": \"\n",
        "      try:\n",
        "        pa_test['valueQuantity']['value']\n",
        "        try:\n",
        "          #context += str(pa_test['valueQuantity']['value']) +\" \"+ str(pa_test['range']) + \"\\n\"\n",
        "          labtest += str(pa_test['valueQuantity']['value']) +\" \"+ str(pa_test['range']) + \"\\n\"\n",
        "        except:\n",
        "          #context += str(pa_test['valueQuantity']['value'])  + \"\\n\"\n",
        "          labtest += str(pa_test['valueQuantity']['value'])  + \"\\n\"\n",
        "      except:\n",
        "        try:\n",
        "          #context += pa_test['valueString'] + \"\\n\"\n",
        "          labtest += pa_test['valueString'] + \"\\n\"\n",
        "        except:\n",
        "          pass\n",
        "  labtests.append(labtest)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "ZVA0FDhPIiF1",
        "outputId": "13c6fdb9-28d6-49d9-b895-6617abfa8b8f"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "True\n"
          ]
        }
      ],
      "source": [
        "if len(vital_sign)==len(date_enc)==len(Drug)==len(Diagnosis)==len(labtests)==len(clinical_exam)==len(Note):\n",
        "  print(\"True\")\n",
        "else:\n",
        "  print(len(vital_sign))\n",
        "  print(len(date_enc))\n",
        "  print(len(Drug))\n",
        "  print(len(Diagnosis))\n",
        "  print(len(labtests))\n",
        "  print(len(clinical_exam))"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "XYdcujnnoS10"
      },
      "outputs": [],
      "source": [
        "#filter enc by group\n",
        "group_dict_seq = {}\n",
        "for group in context_event[0].format.keys():\n",
        "  group_dict_seq[group] = []\n",
        "  for j in range(len(groups)):\n",
        "    if group in groups[j]:\n",
        "      group_dict_seq[group].append(j)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "collapsed": true,
        "id": "2WTZDIo0KY-D"
      },
      "outputs": [],
      "source": [
        "#make content for each group diagnosis\n",
        "context_enc = {}\n",
        "for key in group_dict_seq.keys():\n",
        "  context_enc[key] = []\n",
        "  count = 0\n",
        "  for j in group_dict_seq[key]:\n",
        "    context = \"***\\n\"\n",
        "    if group_drug[key][count].format == None:\n",
        "      group_drug[key][count].format = [\"Do not have drug\"]\n",
        "    if count == 0:\n",
        "      context += \"Khám ngày: \" + date_enc[j] + \"\\n\"\n",
        "      context += \"Khám lâm sàng: \" + clinical_exam[j] + \"\\n\"\n",
        "      context += \"Chẩn đoán: \" + \"\\n\"+ \", \".join(Diagnosis[j][key]) + \"\\n\"\n",
        "      context += \"Thuốc: \" + \", \".join(group_drug[key][count].format) + \"\\n\"\n",
        "      context += \"Note: \" + Note[j] + \"\\n\"\n",
        "      context += \"Vital sign: \" + \"\\n\" + vital_sign[j]\n",
        "      context += \"Xét nghiệm cận lâm sàn:\" + \"\\n\" + labtests[j]\n",
        "      #diag_ref = Diagnosis[j][key]\n",
        "      drug_ref = group_drug[key][count].format\n",
        "    else:\n",
        "      add_drug,dele_drug = changing(drug_ref,group_drug[key][count].format)\n",
        "      if add_drug == \"\" and dele_drug == \"\":\n",
        "        count += 1\n",
        "        continue\n",
        "      else:\n",
        "        context += \"Khám ngày: \" + date_enc[j] + \"\\n\"\n",
        "        context += \"Khám lâm sàng: \" + clinical_exam[j] + \"\\n\"\n",
        "        context += \"Chẩn đoán: \" + \", \".join(Diagnosis[j][key]) + \"\\n\"\n",
        "        context += \"Thuốc: \\n\" + \", \".join(group_drug[key][count].format) + \"\\n\"\n",
        "        context += \"Thêm: \" + add_drug + \"\\n\" + \"Bỏ: \" + dele_drug + \"\\n\"\n",
        "        context += \"Note: \" + Note[j] + \"\\n\"\n",
        "        context += \"Vital sign: \" + \"\\n\" + vital_sign[j]\n",
        "        context += \"Xét nghiệm cận lâm sàn:\" + \"\\n\" + labtests[j]\n",
        "        diag_ref = Diagnosis[j]\n",
        "        drug_ref = group_drug[key][count].format\n",
        "    count += 1\n",
        "    context_enc[key].append(context)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "collapsed": true,
        "id": "kKkSPLt8uVs-",
        "outputId": "09942452-c028-4895-f21a-984006b7e739"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "{'Metabolic Disorders': [0,\n",
              "  1,\n",
              "  2,\n",
              "  4,\n",
              "  5,\n",
              "  6,\n",
              "  7,\n",
              "  8,\n",
              "  9,\n",
              "  10,\n",
              "  11,\n",
              "  12,\n",
              "  13,\n",
              "  14,\n",
              "  15,\n",
              "  17,\n",
              "  18],\n",
              " 'Liver Function Abnormalities': [0, 17, 18],\n",
              " 'Cardiovascular Diseases': [1,\n",
              "  2,\n",
              "  3,\n",
              "  4,\n",
              "  5,\n",
              "  6,\n",
              "  7,\n",
              "  8,\n",
              "  9,\n",
              "  10,\n",
              "  11,\n",
              "  12,\n",
              "  13,\n",
              "  15,\n",
              "  17,\n",
              "  18],\n",
              " 'Gastrointestinal Disorders': [3, 4, 5, 6, 7, 8, 9, 10, 11, 12]}"
            ]
          },
          "execution_count": 49,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "group_dict_seq"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "-xWi6OPBxw9Q",
        "outputId": "c782c722-c934-466d-bf73-2adc03ac487a"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "[extract_drug(format=['Do not have drug']),\n",
              " extract_drug(format=['Do not have drug']),\n",
              " extract_drug(format=['Silygamma'])]"
            ]
          },
          "execution_count": 67,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "group_drug['Liver Function Abnormalities']"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "qixPaFyBxMlf"
      },
      "source": [
        "# Lama3-70b"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "1s--hdp2fOP8",
        "outputId": "29d1a7c4-35b9-47b3-e133-6a6c0f6e8312"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Collecting groq\n",
            "  Downloading groq-0.9.0-py3-none-any.whl (103 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m103.5/103.5 kB\u001b[0m \u001b[31m1.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: anyio<5,>=3.5.0 in /usr/local/lib/python3.10/dist-packages (from groq) (3.7.1)\n",
            "Requirement already satisfied: distro<2,>=1.7.0 in /usr/lib/python3/dist-packages (from groq) (1.7.0)\n",
            "Collecting httpx<1,>=0.23.0 (from groq)\n",
            "  Downloading httpx-0.27.0-py3-none-any.whl (75 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m75.6/75.6 kB\u001b[0m \u001b[31m4.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: pydantic<3,>=1.9.0 in /usr/local/lib/python3.10/dist-packages (from groq) (2.7.4)\n",
            "Requirement already satisfied: sniffio in /usr/local/lib/python3.10/dist-packages (from groq) (1.3.1)\n",
            "Requirement already satisfied: typing-extensions<5,>=4.7 in /usr/local/lib/python3.10/dist-packages (from groq) (4.12.2)\n",
            "Requirement already satisfied: idna>=2.8 in /usr/local/lib/python3.10/dist-packages (from anyio<5,>=3.5.0->groq) (3.7)\n",
            "Requirement already satisfied: exceptiongroup in /usr/local/lib/python3.10/dist-packages (from anyio<5,>=3.5.0->groq) (1.2.1)\n",
            "Requirement already satisfied: certifi in /usr/local/lib/python3.10/dist-packages (from httpx<1,>=0.23.0->groq) (2024.6.2)\n",
            "Collecting httpcore==1.* (from httpx<1,>=0.23.0->groq)\n",
            "  Downloading httpcore-1.0.5-py3-none-any.whl (77 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m77.9/77.9 kB\u001b[0m \u001b[31m6.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hCollecting h11<0.15,>=0.13 (from httpcore==1.*->httpx<1,>=0.23.0->groq)\n",
            "  Downloading h11-0.14.0-py3-none-any.whl (58 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m58.3/58.3 kB\u001b[0m \u001b[31m6.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: annotated-types>=0.4.0 in /usr/local/lib/python3.10/dist-packages (from pydantic<3,>=1.9.0->groq) (0.7.0)\n",
            "Requirement already satisfied: pydantic-core==2.18.4 in /usr/local/lib/python3.10/dist-packages (from pydantic<3,>=1.9.0->groq) (2.18.4)\n",
            "Installing collected packages: h11, httpcore, httpx, groq\n",
            "Successfully installed groq-0.9.0 h11-0.14.0 httpcore-1.0.5 httpx-0.27.0\n"
          ]
        }
      ],
      "source": [
        "pip install groq"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "VlhWb4mRhoKy",
        "outputId": "0dee8733-1faa-4b61-e7d2-0b5f4676669d"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Collecting langchain-groq\n",
            "  Downloading langchain_groq-0.1.6-py3-none-any.whl (14 kB)\n",
            "Requirement already satisfied: groq<1,>=0.4.1 in /usr/local/lib/python3.10/dist-packages (from langchain-groq) (0.9.0)\n",
            "Collecting langchain-core<0.3,>=0.2.2 (from langchain-groq)\n",
            "  Downloading langchain_core-0.2.10-py3-none-any.whl (332 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m332.8/332.8 kB\u001b[0m \u001b[31m2.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: anyio<5,>=3.5.0 in /usr/local/lib/python3.10/dist-packages (from groq<1,>=0.4.1->langchain-groq) (3.7.1)\n",
            "Requirement already satisfied: distro<2,>=1.7.0 in /usr/lib/python3/dist-packages (from groq<1,>=0.4.1->langchain-groq) (1.7.0)\n",
            "Requirement already satisfied: httpx<1,>=0.23.0 in /usr/local/lib/python3.10/dist-packages (from groq<1,>=0.4.1->langchain-groq) (0.27.0)\n",
            "Requirement already satisfied: pydantic<3,>=1.9.0 in /usr/local/lib/python3.10/dist-packages (from groq<1,>=0.4.1->langchain-groq) (2.7.4)\n",
            "Requirement already satisfied: sniffio in /usr/local/lib/python3.10/dist-packages (from groq<1,>=0.4.1->langchain-groq) (1.3.1)\n",
            "Requirement already satisfied: typing-extensions<5,>=4.7 in /usr/local/lib/python3.10/dist-packages (from groq<1,>=0.4.1->langchain-groq) (4.12.2)\n",
            "Requirement already satisfied: PyYAML>=5.3 in /usr/local/lib/python3.10/dist-packages (from langchain-core<0.3,>=0.2.2->langchain-groq) (6.0.1)\n",
            "Collecting jsonpatch<2.0,>=1.33 (from langchain-core<0.3,>=0.2.2->langchain-groq)\n",
            "  Downloading jsonpatch-1.33-py2.py3-none-any.whl (12 kB)\n",
            "Collecting langsmith<0.2.0,>=0.1.75 (from langchain-core<0.3,>=0.2.2->langchain-groq)\n",
            "  Downloading langsmith-0.1.82-py3-none-any.whl (127 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m127.4/127.4 kB\u001b[0m \u001b[31m14.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: packaging<25,>=23.2 in /usr/local/lib/python3.10/dist-packages (from langchain-core<0.3,>=0.2.2->langchain-groq) (24.1)\n",
            "Requirement already satisfied: tenacity!=8.4.0,<9.0.0,>=8.1.0 in /usr/local/lib/python3.10/dist-packages (from langchain-core<0.3,>=0.2.2->langchain-groq) (8.4.1)\n",
            "Requirement already satisfied: idna>=2.8 in /usr/local/lib/python3.10/dist-packages (from anyio<5,>=3.5.0->groq<1,>=0.4.1->langchain-groq) (3.7)\n",
            "Requirement already satisfied: exceptiongroup in /usr/local/lib/python3.10/dist-packages (from anyio<5,>=3.5.0->groq<1,>=0.4.1->langchain-groq) (1.2.1)\n",
            "Requirement already satisfied: certifi in /usr/local/lib/python3.10/dist-packages (from httpx<1,>=0.23.0->groq<1,>=0.4.1->langchain-groq) (2024.6.2)\n",
            "Requirement already satisfied: httpcore==1.* in /usr/local/lib/python3.10/dist-packages (from httpx<1,>=0.23.0->groq<1,>=0.4.1->langchain-groq) (1.0.5)\n",
            "Requirement already satisfied: h11<0.15,>=0.13 in /usr/local/lib/python3.10/dist-packages (from httpcore==1.*->httpx<1,>=0.23.0->groq<1,>=0.4.1->langchain-groq) (0.14.0)\n",
            "Collecting jsonpointer>=1.9 (from jsonpatch<2.0,>=1.33->langchain-core<0.3,>=0.2.2->langchain-groq)\n",
            "  Downloading jsonpointer-3.0.0-py2.py3-none-any.whl (7.6 kB)\n",
            "Collecting orjson<4.0.0,>=3.9.14 (from langsmith<0.2.0,>=0.1.75->langchain-core<0.3,>=0.2.2->langchain-groq)\n",
            "  Downloading orjson-3.10.5-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (144 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m145.0/145.0 kB\u001b[0m \u001b[31m14.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: requests<3,>=2 in /usr/local/lib/python3.10/dist-packages (from langsmith<0.2.0,>=0.1.75->langchain-core<0.3,>=0.2.2->langchain-groq) (2.31.0)\n",
            "Requirement already satisfied: annotated-types>=0.4.0 in /usr/local/lib/python3.10/dist-packages (from pydantic<3,>=1.9.0->groq<1,>=0.4.1->langchain-groq) (0.7.0)\n",
            "Requirement already satisfied: pydantic-core==2.18.4 in /usr/local/lib/python3.10/dist-packages (from pydantic<3,>=1.9.0->groq<1,>=0.4.1->langchain-groq) (2.18.4)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests<3,>=2->langsmith<0.2.0,>=0.1.75->langchain-core<0.3,>=0.2.2->langchain-groq) (3.3.2)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests<3,>=2->langsmith<0.2.0,>=0.1.75->langchain-core<0.3,>=0.2.2->langchain-groq) (2.0.7)\n",
            "Installing collected packages: orjson, jsonpointer, jsonpatch, langsmith, langchain-core, langchain-groq\n",
            "Successfully installed jsonpatch-1.33 jsonpointer-3.0.0 langchain-core-0.2.10 langchain-groq-0.1.6 langsmith-0.1.82 orjson-3.10.5\n"
          ]
        }
      ],
      "source": [
        "pip install langchain-groq"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "csKuTDjmfKwf"
      },
      "outputs": [],
      "source": [
        "api_key = \"API key\"\n",
        "import os\n",
        "\n",
        "from groq import Groq\n",
        "from langchain_groq import ChatGroq\n",
        "llama3 = ChatGroq(temperature=0, model_name=\"llama3-70b-8192\",groq_api_key=api_key)\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "u41OifCcsrrH"
      },
      "source": [
        "# GPT4"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "TgCK3qFWpH7H"
      },
      "source": [
        "**Get Group from enc**"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "IB8rFzAtladp"
      },
      "outputs": [],
      "source": [
        "from langchain_core.pydantic_v1 import BaseModel, Field\n",
        "from langchain.output_parsers import PydanticOutputParser\n",
        "from typing import Optional"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 404
        },
        "id": "k6nrRR9TYsUb",
        "outputId": "d8172845-d24b-4141-a86d-f3faba3f98d6"
      },
      "outputs": [
        {
          "ename": "ModuleNotFoundError",
          "evalue": "No module named 'langchain_community'",
          "output_type": "error",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mModuleNotFoundError\u001b[0m                       Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-1-fcd5e2769a58>\u001b[0m in \u001b[0;36m<cell line: 2>\u001b[0;34m()\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mos\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 2\u001b[0;31m \u001b[0;32mfrom\u001b[0m \u001b[0mlangchain_community\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mcallbacks\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mget_openai_callback\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      3\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0mlangchain\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mprompts\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mPromptTemplate\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      4\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0mlangchain\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mchains\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mLLMChain\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      5\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0mlangchain\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mmemory\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mConversationBufferMemory\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mModuleNotFoundError\u001b[0m: No module named 'langchain_community'",
            "",
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0;32m\nNOTE: If your import is failing due to a missing package, you can\nmanually install dependencies using either !pip or !apt.\n\nTo view examples of installing some common dependencies, click the\n\"Open Examples\" button below.\n\u001b[0;31m---------------------------------------------------------------------------\u001b[0m\n"
          ]
        }
      ],
      "source": [
        "import os\n",
        "from langchain_community.callbacks import get_openai_callback\n",
        "from langchain.prompts import PromptTemplate\n",
        "from langchain.chains import LLMChain\n",
        "from langchain.memory import ConversationBufferMemory\n",
        "os.environ['OPENAI_API_KEY'] = \"API key\"\n",
        "from langchain_openai import ChatOpenAI\n",
        "chat_4 = ChatOpenAI(model = \"gpt-4o-2024-05-13\",temperature = 0)\n",
        "chat_3 = ChatOpenAI(model = \"gpt-3.5-turbo\",temperature = 0)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "collapsed": true,
        "id": "foqjxXQQlfpc"
      },
      "outputs": [],
      "source": [
        "class group_diag(BaseModel):\n",
        "  format: Optional[dict] =  Field(None,description=\"key is the name of the group and value is the name of diagnosis in corresponding group\")\n",
        "\n",
        "parser = PydanticOutputParser(pydantic_object=group_diag)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 231
        },
        "collapsed": true,
        "id": "plvCnO0Ns88c",
        "outputId": "51c6ca8d-89b5-4ba4-ea84-3bf9e2d713f0"
      },
      "outputs": [
        {
          "ename": "NameError",
          "evalue": "name 'PromptTemplate' is not defined",
          "output_type": "error",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-2-4561cf55522f>\u001b[0m in \u001b[0;36m<cell line: 2>\u001b[0;34m()\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[0;31m#prompt for classify diags\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 2\u001b[0;31m prompt = PromptTemplate(\n\u001b[0m\u001b[1;32m      3\u001b[0m     template = \"\"\"here are the diagnosis that i have had. As a doctor, could you classify them into groups for me easy to watching the process diseases.\n\u001b[1;32m      4\u001b[0m   \u001b[0;34m{\u001b[0m\u001b[0mtext\u001b[0m\u001b[0;34m}\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      5\u001b[0m   \u001b[0mOutput\u001b[0m \u001b[0mformat\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mNameError\u001b[0m: name 'PromptTemplate' is not defined"
          ]
        }
      ],
      "source": [
        "#prompt for classify diags\n",
        "prompt = PromptTemplate(\n",
        "    template = \"\"\"here are the diagnosis that i have had. As a doctor, could you classify them into groups for me easy to watching the process diseases.\n",
        "  {text}\n",
        "  Output format:\n",
        "  {format_instructions}\n",
        "     \"\"\",\n",
        "    input_variables=[\"text\"],\n",
        "    partial_variables={\"format_instructions\": parser.get_format_instructions()},\n",
        ")\n",
        "\n",
        "chain_group = LLMChain(prompt = prompt,\n",
        "                 llm = chat_4)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "collapsed": true,
        "id": "h0m-zuFntK5E",
        "outputId": "bc3da784-bd4d-4336-ecb0-8d138568ab5b"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "```json\n",
            "{\n",
            "  \"format\": {\n",
            "    \"Metabolic Disorders\": [\n",
            "      \"E78 - Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác\",\n",
            "      \"E11 - Bệnh đái tháo đường không phụ thuộc insuline\"\n",
            "    ],\n",
            "    \"Liver Function Abnormalities\": [\n",
            "      \"R94.5 - Kết quả bất thường về thăm dò chức năng gan\"\n",
            "    ],\n",
            "    \"Cardiovascular Diseases\": [\n",
            "      \"I10 - Bệnh tăng huyết áp vô căn (nguyên phát)\",\n",
            "      \"I25.5 - Bệnh cơ tim do thiếu máu cục bộ\",\n",
            "      \"I83 - Dãn tĩnh mạch chi dưới\"\n",
            "    ],\n",
            "    \"Gastrointestinal Disorders\": [\n",
            "      \"K29 - Viêm dạ dày và tá tràng\",\n",
            "      \"K58 - Hội chứng ruột kích thích\"\n",
            "    ]\n",
            "  }\n",
            "}\n",
            "```\n",
            "\n",
            "Total Tokens: 541\n",
            "Prompt Tokens: 337\n",
            "Completion Tokens: 204\n",
            "Total Cost (USD): $0.004745\n"
          ]
        }
      ],
      "source": [
        "cost = 0\n",
        "context_event = []\n",
        "with get_openai_callback() as cb:\n",
        "  output = chain_group.predict(text = all_diag_text)\n",
        "  context_event.append(parser.invoke(output))\n",
        "  print(output)\n",
        "  print()\n",
        "  print(f\"Total Tokens: {cb.total_tokens}\")\n",
        "  print(f\"Prompt Tokens: {cb.prompt_tokens}\")\n",
        "  print(f\"Completion Tokens: {cb.completion_tokens}\")\n",
        "  print(f\"Total Cost (USD): ${cb.total_cost}\")\n",
        "  cost += cb.total_cost"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "GZby8LURpQjk"
      },
      "source": [
        "**Summary by AI**"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "qCicuVY8ZbmU"
      },
      "outputs": [],
      "source": [
        "#prompt for extract info each encounter\n",
        "class extract_drug(BaseModel):\n",
        "  format: Optional[list] =  Field(None,description=\"List of extracted drugs using in each encounter\")\n",
        "\n",
        "parser_drug = PydanticOutputParser(pydantic_object=extract_drug)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "uadAmmkjZ_ST"
      },
      "outputs": [],
      "source": [
        "#prompt for each enc\n",
        "prompt = PromptTemplate(\n",
        "    template = \"\"\"here is the drugs in an encounter. As a doctor, could you extract the drugs, which treating diseases {diags}.\n",
        "\n",
        "  The drugs:\n",
        "  {text}\n",
        "\n",
        "  Output responses only name of the extracted drugs (Base on name in the list of drug above)\n",
        "  If you do not find the drugs, output is a list with string \"Do not have drug\"\n",
        "  Output format:\n",
        "  {format_instructions}\n",
        "     \"\"\",\n",
        "    input_variables=[\"text\",'diags'],\n",
        "    partial_variables={\"format_instructions\": parser_drug.get_format_instructions()},\n",
        ")\n",
        "\n",
        "chain_extract = LLMChain(prompt = prompt,\n",
        "                 llm = chat_3)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "collapsed": true,
        "id": "05q8maxIcZjl",
        "outputId": "1ccd2d70-2b25-425e-cbdd-4eedb80324e0"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "format=['Simvastatin', 'Metformin']\n",
            "\n",
            "Total Tokens: 305\n",
            "Prompt Tokens: 288\n",
            "Completion Tokens: 17\n",
            "Total Cost (USD): $0.000466\n",
            "format=['Metformin hydrochloride', 'Simvastatin', 'Ezetimib', 'Telmisartan', 'Hydrochlorothiazid']\n",
            "\n",
            "Total Tokens: 407\n",
            "Prompt Tokens: 366\n",
            "Completion Tokens: 41\n",
            "Total Cost (USD): $0.000631\n",
            "format=['Glucophage ® XR 500 mg', 'Biovacor']\n",
            "\n",
            "Total Tokens: 361\n",
            "Prompt Tokens: 339\n",
            "Completion Tokens: 22\n",
            "Total Cost (USD): $0.0005525\n",
            "format=['Atorvastatin', 'Metformin']\n",
            "\n",
            "Total Tokens: 468\n",
            "Prompt Tokens: 450\n",
            "Completion Tokens: 18\n",
            "Total Cost (USD): $0.000711\n",
            "format=['Glucophage 500mg', 'Simvastar tablet 20mg']\n",
            "\n",
            "Total Tokens: 478\n",
            "Prompt Tokens: 454\n",
            "Completion Tokens: 24\n",
            "Total Cost (USD): $0.000729\n",
            "format=['Metformin', 'Simvastatin']\n",
            "\n",
            "Total Tokens: 460\n",
            "Prompt Tokens: 443\n",
            "Completion Tokens: 17\n",
            "Total Cost (USD): $0.0006985\n",
            "format=['Agirovastin 10', 'Galvus']\n",
            "\n",
            "Total Tokens: 467\n",
            "Prompt Tokens: 447\n",
            "Completion Tokens: 20\n",
            "Total Cost (USD): $0.0007105\n",
            "format=['Silygamma', 'SaVi Bezafibrate']\n",
            "\n",
            "Total Tokens: 447\n",
            "Prompt Tokens: 429\n",
            "Completion Tokens: 18\n",
            "Total Cost (USD): $0.0006795\n",
            "format=['Lipagim 200', 'Agitritine 200']\n",
            "\n",
            "Total Tokens: 514\n",
            "Prompt Tokens: 492\n",
            "Completion Tokens: 22\n",
            "Total Cost (USD): $0.000782\n",
            "format=['Fenostad 200', 'Silygamma']\n",
            "\n",
            "Total Tokens: 423\n",
            "Prompt Tokens: 404\n",
            "Completion Tokens: 19\n",
            "Total Cost (USD): $0.000644\n",
            "format=['Fenostad 200', 'Silygamma']\n",
            "\n",
            "Total Tokens: 506\n",
            "Prompt Tokens: 487\n",
            "Completion Tokens: 19\n",
            "Total Cost (USD): $0.0007685000000000001\n",
            "format=['Ravastel-20', 'Sitagibes 50']\n",
            "\n",
            "Total Tokens: 575\n",
            "Prompt Tokens: 553\n",
            "Completion Tokens: 22\n",
            "Total Cost (USD): $0.0008735\n",
            "format=['Simvastatin', 'Metformin']\n",
            "\n",
            "Total Tokens: 305\n",
            "Prompt Tokens: 288\n",
            "Completion Tokens: 17\n",
            "Total Cost (USD): $0.000466\n",
            "format=['Meglucon 1000', 'Diamicron MR 60mg', 'Ezensimva 10/10', 'Sitagibes 100']\n",
            "\n",
            "Total Tokens: 505\n",
            "Prompt Tokens: 464\n",
            "Completion Tokens: 41\n",
            "Total Cost (USD): $0.000778\n",
            "format=['Nebilet', 'Meglucon 1000', 'Ramipril GP', 'Ezensimva 10/10', 'Sitagibes 100', 'Dorocron MR 60 mg']\n",
            "\n",
            "Total Tokens: 520\n",
            "Prompt Tokens: 467\n",
            "Completion Tokens: 53\n",
            "Total Cost (USD): $0.0008065\n",
            "format=['Simvastatin', 'Metformin']\n",
            "\n",
            "Total Tokens: 305\n",
            "Prompt Tokens: 288\n",
            "Completion Tokens: 17\n",
            "Total Cost (USD): $0.000466\n",
            "format=['Atorvastatin', 'Glimepiride', 'Metformin hydroclorid', 'Sitagliptin']\n",
            "\n",
            "Total Tokens: 466\n",
            "Prompt Tokens: 432\n",
            "Completion Tokens: 34\n",
            "Total Cost (USD): $0.0007160000000000001\n",
            "format=['Drug A', 'Drug B']\n",
            "\n",
            "Total Tokens: 275\n",
            "Prompt Tokens: 261\n",
            "Completion Tokens: 14\n",
            "Total Cost (USD): $0.0004195\n",
            "format=['Drug A', 'Drug B']\n",
            "\n",
            "Total Tokens: 275\n",
            "Prompt Tokens: 261\n",
            "Completion Tokens: 14\n",
            "Total Cost (USD): $0.0004195\n",
            "format=['Atorvastatin', 'Glimepiride', 'Metformin hydroclorid', 'Silymarin', 'Telmisartan', 'Hydroclorothiazid', 'Sitagliptin']\n",
            "\n",
            "Total Tokens: 461\n",
            "Prompt Tokens: 405\n",
            "Completion Tokens: 56\n",
            "Total Cost (USD): $0.0007195000000000001\n",
            "format=['Metformin hydrochloride', 'Simvastatin', 'Ezetimib', 'Telmisartan', 'Hydrochlorothiazid']\n",
            "\n",
            "Total Tokens: 428\n",
            "Prompt Tokens: 387\n",
            "Completion Tokens: 41\n",
            "Total Cost (USD): $0.0006625000000000001\n",
            "format=['Metformin hydrochloride', 'Valsartan', 'Pravastatin natri']\n",
            "\n",
            "Total Tokens: 387\n",
            "Prompt Tokens: 360\n",
            "Completion Tokens: 27\n",
            "Total Cost (USD): $0.000594\n",
            "format=['Omeprazol 20mg', 'Nebivolol 5']\n",
            "\n",
            "Total Tokens: 479\n",
            "Prompt Tokens: 455\n",
            "Completion Tokens: 24\n",
            "Total Cost (USD): $0.0007305\n",
            "format=['Atorvastatin', 'Perindopril arginin', 'Metformin hydrochloride', 'Pantoprazol']\n",
            "\n",
            "Total Tokens: 507\n",
            "Prompt Tokens: 471\n",
            "Completion Tokens: 36\n",
            "Total Cost (USD): $0.0007785\n",
            "format=['Pantoprazol', 'Metformin', 'Simvastatin', 'Bismuth oxyd', 'Ramipril', 'Metoprolol']\n",
            "\n",
            "Total Tokens: 517\n",
            "Prompt Tokens: 475\n",
            "Completion Tokens: 42\n",
            "Total Cost (USD): $0.0007965\n",
            "format=['Bisoprolol 2.5', 'Perindopril 5', 'Simvastatin Savi 20']\n",
            "\n",
            "Total Tokens: 499\n",
            "Prompt Tokens: 464\n",
            "Completion Tokens: 35\n",
            "Total Cost (USD): $0.000766\n",
            "format=['Bisoprolol 2,5mg Tablets', 'A.T Perindopril 5', 'Agirovastin 10']\n",
            "\n",
            "Total Tokens: 506\n",
            "Prompt Tokens: 468\n",
            "Completion Tokens: 38\n",
            "Total Cost (USD): $0.000778\n",
            "format=['Bisoprolol 2,5mg Tablets', 'Ramizes 5']\n",
            "\n",
            "Total Tokens: 475\n",
            "Prompt Tokens: 450\n",
            "Completion Tokens: 25\n",
            "Total Cost (USD): $0.0007250000000000001\n",
            "format=['Bisoprolol 2,5mg Tablets', 'Ramipril GP', 'Lipagim 200']\n",
            "\n",
            "Total Tokens: 546\n",
            "Prompt Tokens: 513\n",
            "Completion Tokens: 33\n",
            "Total Cost (USD): $0.0008355\n",
            "format=['Bisoprolol 2,5mg Tablets', 'Flodilan - 2', 'Ramizes 5']\n",
            "\n",
            "Total Tokens: 458\n",
            "Prompt Tokens: 425\n",
            "Completion Tokens: 33\n",
            "Total Cost (USD): $0.0007035\n",
            "format=['Bisoprolol 2,5mg Tablets', 'Dogastrol 40 mg', 'Fenostad 200', 'Silygamma', 'Beynit 2.5']\n",
            "\n",
            "Total Tokens: 557\n",
            "Prompt Tokens: 508\n",
            "Completion Tokens: 49\n",
            "Total Cost (USD): $0.00086\n",
            "format=['Pantoprazol', 'Mebeverin hydroclorid', 'Rosuvastatin', 'Ramipril', 'Sitagliptin', 'Diệp hạ châu']\n",
            "\n",
            "Total Tokens: 624\n",
            "Prompt Tokens: 574\n",
            "Completion Tokens: 50\n",
            "Total Cost (USD): $0.000961\n",
            "format=['Losartan', 'Amlodipine', 'Aspirin', 'Clopidogrel', 'Warfarin', 'Heparin', 'Compression stockings']\n",
            "\n",
            "Total Tokens: 352\n",
            "Prompt Tokens: 309\n",
            "Completion Tokens: 43\n",
            "Total Cost (USD): $0.0005495\n",
            "format=['Nebilet', 'Ramipril GP', 'Ezensimva 10/10']\n",
            "\n",
            "Total Tokens: 515\n",
            "Prompt Tokens: 488\n",
            "Completion Tokens: 27\n",
            "Total Cost (USD): $0.000786\n",
            "format=['Losartan', 'Amlodipine', 'Metoprolol', 'Aspirin', 'Clopidogrel', 'Rivaroxaban']\n",
            "\n",
            "Total Tokens: 350\n",
            "Prompt Tokens: 309\n",
            "Completion Tokens: 41\n",
            "Total Cost (USD): $0.0005455\n",
            "format=['Atorvastatin', 'Telmisartan', 'Hydroclorothiazid']\n",
            "\n",
            "Total Tokens: 482\n",
            "Prompt Tokens: 453\n",
            "Completion Tokens: 29\n",
            "Total Cost (USD): $0.0007375\n",
            "format=['Omeprazol', 'Tiram', 'Varogel']\n",
            "\n",
            "Total Tokens: 436\n",
            "Prompt Tokens: 414\n",
            "Completion Tokens: 22\n",
            "Total Cost (USD): $0.000665\n",
            "format=['Sipantoz 20']\n",
            "\n",
            "Total Tokens: 444\n",
            "Prompt Tokens: 430\n",
            "Completion Tokens: 14\n",
            "Total Cost (USD): $0.000673\n",
            "format=['Dogastrol 40 mg', 'Bisnol']\n",
            "\n",
            "Total Tokens: 454\n",
            "Prompt Tokens: 434\n",
            "Completion Tokens: 20\n",
            "Total Cost (USD): $0.000691\n",
            "format=['Omeprazol 20mg', 'Bisnol']\n",
            "\n",
            "Total Tokens: 445\n",
            "Prompt Tokens: 423\n",
            "Completion Tokens: 22\n",
            "Total Cost (USD): $0.0006785\n",
            "format=['Agirovastin 10', 'Agitritine 200']\n",
            "\n",
            "Total Tokens: 450\n",
            "Prompt Tokens: 427\n",
            "Completion Tokens: 23\n",
            "Total Cost (USD): $0.0006865\n",
            "format=['Rabeprazol 20', 'Agitritine 200']\n",
            "\n",
            "Total Tokens: 432\n",
            "Prompt Tokens: 409\n",
            "Completion Tokens: 23\n",
            "Total Cost (USD): $0.0006595\n",
            "format=['Martaz', 'Atiliver Diệp hạ châu']\n",
            "\n",
            "Total Tokens: 495\n",
            "Prompt Tokens: 472\n",
            "Completion Tokens: 23\n",
            "Total Cost (USD): $0.000754\n",
            "format=['Rabeprazol natri 20mg', 'Trimebutine maleate 150mg']\n",
            "\n",
            "Total Tokens: 413\n",
            "Prompt Tokens: 384\n",
            "Completion Tokens: 29\n",
            "Total Cost (USD): $0.000634\n",
            "format=['Dogastrol 40 mg', 'Beynit 2.5']\n",
            "\n",
            "Total Tokens: 490\n",
            "Prompt Tokens: 467\n",
            "Completion Tokens: 23\n",
            "Total Cost (USD): $0.0007465000000000001\n",
            "format=['Dogastrol 40 mg', 'L-BIO-3D', 'Verimed 135mg']\n",
            "\n",
            "Total Tokens: 562\n",
            "Prompt Tokens: 533\n",
            "Completion Tokens: 29\n",
            "Total Cost (USD): $0.0008575000000000001\n"
          ]
        }
      ],
      "source": [
        "group_drug = {}\n",
        "for name_group in context_event[0].format.keys():\n",
        "  for i in group_dict_seq[name_group]:\n",
        "    with get_openai_callback() as cb:\n",
        "      output = chain_extract.predict(text = \", \".join(Drug[i]),diags = \", \".join(context_event[0].format[name_group]))\n",
        "      print(parser_drug.invoke(output))\n",
        "      try:\n",
        "        group_drug[name_group].append(parser_drug.invoke(output))\n",
        "      except:\n",
        "        group_drug[name_group] = [(parser_drug.invoke(output))]\n",
        "      print()\n",
        "      print(f\"Total Tokens: {cb.total_tokens}\")\n",
        "      print(f\"Prompt Tokens: {cb.prompt_tokens}\")\n",
        "      print(f\"Completion Tokens: {cb.completion_tokens}\")\n",
        "      print(f\"Total Cost (USD): ${cb.total_cost}\")\n",
        "      cost += cb.total_cost"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "dcpeVRLopV0Z"
      },
      "outputs": [],
      "source": [
        "#prompt for abstract each encounter\n",
        "prompt_abstract_enc = PromptTemplate(\n",
        "    template = \"\"\"You are an assistant doctor, special in {key_group}. Base on the patient's information, please help me answer these questions of each encounter.\n",
        "  1. Date of encounter\n",
        "  2. The laboratory tests support for {diags} (if has).\n",
        "  3. Extract the drug's information (add in, remove). Then answer these question:\n",
        "  Why does it change? . Give the evidence (base on the patient's information). Do not add external information\n",
        "  4. Surgery or interference information (if has)\n",
        "\n",
        "Here is the patient's information:\n",
        "{patient_inf}\n",
        "     \"\"\",\n",
        "    input_variables=[\"key_group\",\"diags\",\"patient_inf\"]\n",
        ")\n",
        "chain_abstract = LLMChain(prompt = prompt_abstract_enc,\n",
        "                 llm = llama3)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "collapsed": true,
        "id": "vmynOvHZvvJl",
        "outputId": "b7450fe8-401c-491c-b54e-f42a13ad9bd6"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "I'd be happy to help you answer the questions based on the patient's information.\n",
            "\n",
            "**1. Date of encounter**\n",
            "The date of encounter is December 20, 2020.\n",
            "\n",
            "**2. Laboratory tests supporting E78 - Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác, E11 - Bệnh đái tháo đường không phụ thuộc insuline (if has)**\n",
            "The laboratory tests supporting E78 include:\n",
            "- Cholesterol toàn phần: 6.87 (high)\n",
            "- Triglycerid: 4.55 (high)\n",
            "- LDL. C: 4.33 (high)\n",
            "- HDL. C: 1.63 (low)\n",
            "\n",
            "The laboratory test supporting E11 is:\n",
            "- Glucose: 6.3 (high)\n",
            "- Glucose (Urine): 151 (+)\n",
            "\n",
            "**3. Extract the drug's information (add in, remove)**\n",
            "There is no drug information available in the patient's record.\n",
            "\n",
            "**4. Surgery or interference information (if has)**\n",
            "There is no surgery or interference information available in the patient's record.\n",
            "\n",
            "Total Tokens: 1686\n",
            "Prompt Tokens: 1460\n",
            "Completion Tokens: 226\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 15/02/2022\n",
            "\n",
            "**2. Laboratory tests support:** \n",
            "- E78: Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác (Disorders of lipoprotein metabolism and other lipidemias)\n",
            "- E11: Bệnh đái tháo đường không phụ thuộc insuline (Type 2 diabetes mellitus)\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** \n",
            "- Glucophage ® XR 500 mg\n",
            "- Stazemid 20/10\n",
            "\n",
            "**Removed:** None\n",
            "\n",
            "**Why did it change?** \n",
            "The patient was diagnosed with Type 2 diabetes mellitus (E11) and disorders of lipoprotein metabolism and other lipidemias (E78). The medications Glucophage XR 500 mg and Stazemid 20/10 were added to manage these conditions. Glucophage XR is an oral anti-diabetic medication that helps to lower blood sugar levels, and Stazemid is a combination of two medications that helps to lower cholesterol levels and reduce the risk of heart disease.\n",
            "\n",
            "**Evidence:** The patient's diagnosis and the addition of these medications support this conclusion.\n",
            "\n",
            "**4. Surgery or interference information:** None\n",
            "\n",
            "Total Tokens: 574\n",
            "Prompt Tokens: 315\n",
            "Completion Tokens: 259\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 15/03/2022\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "- E78: Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác (Disorders of lipoprotein metabolism and other lipidemias)\n",
            "- E11: Bệnh đái tháo đường không phụ thuộc insuline (Type 2 diabetes mellitus)\n",
            "\n",
            "**3. Drug information:**\n",
            "- Added: Biovacor\n",
            "- Removed: Stazemid 20/10\n",
            "- Continued: Glucophage ® XR 500 mg, Biovacor\n",
            "\n",
            "**Why did the doctor change the medication?**\n",
            "The doctor added Biovacor, which is likely a lipid-lowering medication, to help manage the patient's lipid disorder (E78). The doctor also removed Stazemid 20/10, which may not be effective in controlling the patient's lipid levels or blood sugar levels. The continued use of Glucophage ® XR 500 mg suggests that the patient's blood sugar levels are still not well-controlled, and the doctor wants to maintain this medication to help manage the patient's type 2 diabetes (E11).\n",
            "\n",
            "**Evidence:**\n",
            "The patient's diagnosis of E78 (Disorders of lipoprotein metabolism and other lipidemias) and E11 (Type 2 diabetes mellitus) suggests that the doctor is trying to manage the patient's lipid levels and blood sugar levels. The addition of Biovacor, a lipid-lowering medication, and the removal of Stazemid 20/10, which may not be effective in controlling lipid levels, support this conclusion.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned.\n",
            "\n",
            "Total Tokens: 653\n",
            "Prompt Tokens: 300\n",
            "Completion Tokens: 353\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 12/04/2022\n",
            "\n",
            "**2. Laboratory tests support for E78 and E11:** \n",
            "- Glucose: 6.8 (normal range: 3.9-7) \n",
            "- HbA1C: 7 (normal range: 4.6-6.2)\n",
            "\n",
            "**3. Drug information:**\n",
            "- Added: Atorvastatin 20 mg\n",
            "- Removed: Biovacor\n",
            "- Continued: Atorvastatin 20 mg, Glucophage ® XR 500 mg\n",
            "\n",
            "**Why did the doctor change the medication?**\n",
            "The doctor added Atorvastatin 20 mg to the patient's medication regimen, which is a statin used to treat high cholesterol. This is likely because the patient has E78 - Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác (Disorders of lipoprotein metabolism and other lipidemias). The doctor also removed Biovacor, which is likely due to its potential interaction with Atorvastatin or its ineffectiveness in treating the patient's condition.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned.\n",
            "\n",
            "Total Tokens: 614\n",
            "Prompt Tokens: 365\n",
            "Completion Tokens: 249\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 10/05/2022\n",
            "\n",
            "**2. Laboratory tests support:** \n",
            "- E78: Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác (supported by the presence of Simvastar tablet 20mg, which is a lipid-lowering medication)\n",
            "- E11: Bệnh đái tháo đường không phụ thuộc insuline (supported by the presence of Glucophage 500mg, which is an oral anti-diabetic medication)\n",
            "\n",
            "**3. Drug information:**\n",
            "- Added: None\n",
            "- Removed: Atorvastatin 20 mg, Glucophage ® XR 500 mg\n",
            "- Continued: Glucophage 500mg, Simvastar tablet 20mg\n",
            "\n",
            "**Why did the doctor change the medication?**\n",
            "The doctor removed Atorvastatin 20 mg, which is a lipid-lowering medication, and replaced it with Simvastar tablet 20mg, which is also a lipid-lowering medication. This change might be due to the patient's response to the medication or potential side effects. Additionally, the doctor removed Glucophage ® XR 500 mg and replaced it with Glucophage 500mg, which is a different formulation of the same medication. This change might be due to the patient's response to the medication or potential side effects.\n",
            "\n",
            "**Evidence:** The patient's medical history and current medication list suggest that the doctor is trying to optimize the patient's lipid profile and blood sugar control.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in the patient's information.\n",
            "\n",
            "Total Tokens: 656\n",
            "Prompt Tokens: 324\n",
            "Completion Tokens: 332\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 07/06/2022\n",
            "\n",
            "**2. Laboratory tests support:** \n",
            "- E78: Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác (Disorders of lipoprotein metabolism and other lipidemias)\n",
            "- E11: Bệnh đái tháo đường không phụ thuộc insuline (Type 2 diabetes mellitus)\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** \n",
            "- Metformin 500mg\n",
            "- Simvastatin Savi 20\n",
            "\n",
            "**Removed:**\n",
            "- Glucophage 500mg\n",
            "- Simvastar tablet 20mg\n",
            "\n",
            "**Why did it change?**\n",
            "The medications were changed to improve the patient's glycemic control and lipid profile. Metformin is an oral anti-diabetic medication that helps to reduce blood sugar levels, and Simvastatin is a statin that helps to lower cholesterol levels. The change from Glucophage to Metformin may be due to the need for a more effective or better-tolerated medication for the patient's type 2 diabetes. The change from Simvastar to Simvastatin Savi may be due to a change in the brand or formulation of the medication.\n",
            "\n",
            "**Evidence:** The patient's diagnosis of type 2 diabetes and disorders of lipoprotein metabolism and other lipidemias suggests that the medications were changed to better manage these conditions.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned.\n",
            "\n",
            "Total Tokens: 630\n",
            "Prompt Tokens: 322\n",
            "Completion Tokens: 308\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 05/07/2022\n",
            "\n",
            "**2. Laboratory tests support:** \n",
            "- E78: Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác (Disorders of lipoprotein metabolism and other lipidemias)\n",
            "- E11: Bệnh đái tháo đường không phụ thuộc insuline (Type 2 diabetes mellitus)\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Agirovastin 10, Galvus\n",
            "**Removed:** Metformin 500mg, Simvastatin Savi 20\n",
            "\n",
            "**Why did the medication change?**\n",
            "The medication was changed to better manage the patient's lipid profile and blood sugar levels. Agirovastin 10 is a lipid-lowering medication, and Galvus is a medication used to treat type 2 diabetes. The patient was previously taking Metformin, which is also used to treat type 2 diabetes, but it was discontinued. Simvastatin Savi 20, a lipid-lowering medication, was also discontinued and replaced with Agirovastin 10.\n",
            "\n",
            "**Evidence:** The patient's diagnosis of E78 (Disorders of lipoprotein metabolism and other lipidemias) and E11 (Type 2 diabetes mellitus) suggests that the medication change was made to better manage these conditions.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned.\n",
            "\n",
            "Total Tokens: 611\n",
            "Prompt Tokens: 314\n",
            "Completion Tokens: 297\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help you answer the questions based on the patient's information.\n",
            "\n",
            "**1. Date of encounter**\n",
            "The date of encounter is August 2, 2022.\n",
            "\n",
            "**2. Laboratory tests supporting the diagnosis**\n",
            "The laboratory tests support the diagnosis of E78 - Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác (Disorders of lipoprotein metabolism and other lipidemias) and E11 - Bệnh đái tháo đường không phụ thuộc insuline (Type 2 diabetes mellitus).\n",
            "\n",
            "**3. Drug information**\n",
            "The patient is currently taking:\n",
            "* Sitagibes 50\n",
            "* SaVi Bezafibrate 200\n",
            "\n",
            "The following medications have been added:\n",
            "* Sitagibes 50\n",
            "* SaVi Bezafibrate 200\n",
            "\n",
            "The following medications have been removed:\n",
            "* Agirovastin 10\n",
            "* Galvus\n",
            "\n",
            "**Why were the medications changed?**\n",
            "The medications were changed likely due to the patient's abnormal laboratory results, including elevated cholesterol and triglyceride levels, indicating the need for more aggressive lipid-lowering therapy. Additionally, the patient's glucose levels are elevated, indicating the need for continued diabetes management.\n",
            "\n",
            "**Evidence from the patient's information:**\n",
            "The patient's laboratory results show elevated cholesterol (5 mmol/L) and triglyceride (3.3 mmol/L) levels, indicating the need for lipid-lowering therapy. The patient's glucose level (7.1 mmol/L) and HbA1C (6.9%) indicate the need for continued diabetes management.\n",
            "\n",
            "**4. Surgery or interference information**\n",
            "There is no information about surgery or interference in the patient's record.\n",
            "\n",
            "Total Tokens: 1906\n",
            "Prompt Tokens: 1561\n",
            "Completion Tokens: 345\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 30/08/2022\n",
            "\n",
            "**2. Laboratory tests support:** \n",
            "- E78: Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác (Disorder of lipoprotein metabolism and other lipidemias)\n",
            "- No evidence of E11 (Type 2 diabetes) in this encounter.\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Meyersiliptin 25, Lipagim 200\n",
            "**Removed:** Sitagibes 50, SaVi Bezafibrate 200\n",
            "\n",
            "**Why did the medication change?**\n",
            "The medication was changed to better manage the patient's lipid disorder. Meyersiliptin 25 and Lipagim 200 were added to help lower lipid levels, while Sitagibes 50 and SaVi Bezafibrate 200 were removed, possibly due to ineffective treatment or side effects.\n",
            "\n",
            "**Evidence:** The patient's diagnosis of E78 (Disorder of lipoprotein metabolism and other lipidemias) suggests that the medication change was made to address the patient's lipid disorder.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in this encounter.\n",
            "\n",
            "Total Tokens: 545\n",
            "Prompt Tokens: 301\n",
            "Completion Tokens: 244\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 27/09/2022\n",
            "\n",
            "**2. Laboratory tests support:** \n",
            "- E78: Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác (Disorders of lipoprotein metabolism and other lipidemias)\n",
            "- E11: Bệnh đái tháo đường không phụ thuộc insuline (Type 2 diabetes mellitus)\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Flodilan - 2, Fenostad 200\n",
            "**Removed:** Meyersiliptin 25, Lipagim 200\n",
            "\n",
            "**Why did it change?**\n",
            "The patient's medication was adjusted to better manage their Type 2 diabetes and lipid disorders. The addition of Flodilan and Fenostad may be due to the need for more effective lipid-lowering therapy, while Meyersiliptin and Lipagim were removed, possibly due to inadequate response or side effects.\n",
            "\n",
            "**Evidence:** The patient's diagnosis of E11 (Type 2 diabetes) and E78 (Disorders of lipoprotein metabolism and other lipidemias) suggests that their medication regimen was adjusted to better manage these conditions.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned.\n",
            "\n",
            "Total Tokens: 571\n",
            "Prompt Tokens: 314\n",
            "Completion Tokens: 257\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 25/10/2022\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "- E78: Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác (Disorders of lipoprotein metabolism and other lipidemias)\n",
            "- E11: Bệnh đái tháo đường không phụ thuộc insuline (Type 2 diabetes mellitus)\n",
            "\n",
            "**3. Drug information:**\n",
            "- Added: Sitagibes 50\n",
            "- Removed: Flodilan - 2\n",
            "- Current medications: Fenostad 200, Sitagibes 50\n",
            "\n",
            "**Why did the medication change?**\n",
            "The medication was changed to add Sitagibes 50, which is likely an oral anti-diabetic medication to help manage the patient's type 2 diabetes (E11). Flodilan - 2 was removed, possibly due to its potential interactions with the new medication or its ineffectiveness in managing the patient's condition.\n",
            "\n",
            "**Evidence:** The patient's diagnosis of type 2 diabetes (E11) and the addition of Sitagibes 50, an oral anti-diabetic medication, suggest that the medication change was made to better manage the patient's blood sugar levels.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned.\n",
            "\n",
            "Total Tokens: 573\n",
            "Prompt Tokens: 302\n",
            "Completion Tokens: 271\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help you answer the questions based on the patient's information.\n",
            "\n",
            "**1. Date of encounter:** 22/11/2022\n",
            "\n",
            "**2. Laboratory tests support:** \n",
            "- E78: Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác (Disorders of lipoprotein metabolism and other lipidemias)\n",
            "- E11: Bệnh đái tháo đường không phụ thuộc insuline (Type 2 diabetes mellitus)\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Ravastel-20, Ramipril GP\n",
            "**Removed:** Fenostad 200\n",
            "\n",
            "**Why did the doctor change the medication?**\n",
            "The doctor likely changed the medication to better manage the patient's lipid disorders and type 2 diabetes. Ravastel-20 is a statin that helps lower cholesterol levels, and Ramipril GP is an ACE inhibitor that can help manage blood pressure and reduce the risk of cardiovascular disease. The removal of Fenostad 200 may be due to its potential to increase liver enzymes, which is a concern given the patient's elevated liver enzymes (Tăng men gan).\n",
            "\n",
            "**Evidence:** The patient's diagnosis of E78 and E11, as well as the presence of elevated liver enzymes and GERD, suggest that the doctor is trying to optimize the patient's medication regimen to manage their metabolic disorders.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in the patient's information.\n",
            "\n",
            "Total Tokens: 614\n",
            "Prompt Tokens: 319\n",
            "Completion Tokens: 295\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help you answer the questions based on the patient's information.\n",
            "\n",
            "**1. Date of encounter**\n",
            "The date of encounter is 08/12/2022.\n",
            "\n",
            "**2. Laboratory tests supporting E78 - Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác, E11 - Bệnh đái tháo đường không phụ thuộc insuline (if has)**\n",
            "The laboratory tests supporting E78 are:\n",
            "- Cholesterol toàn phần: 6.02 (high)\n",
            "- Triglycerid: 4.13 (high)\n",
            "- LDL. C: 3.75 (high)\n",
            "- HDL. C: 1.44 (low)\n",
            "\n",
            "There is no evidence of E11 - Bệnh đái tháo đường không phụ thuộc insuline (Type 2 diabetes) based on the laboratory tests.\n",
            "\n",
            "**3. Extract the drug's information (add in, remove)**\n",
            "The patient is not currently taking any medications. The removed medications are:\n",
            "- Ravastel-20\n",
            "- Ramipril GP\n",
            "- Sitagibes 50\n",
            "\n",
            "**Why does it change?**\n",
            "The medications were removed due to the patient's current health status and laboratory test results, which indicate high cholesterol and triglyceride levels, and low HDL-C levels. The medications may have been removed to adjust the treatment plan to better manage the patient's lipid profile.\n",
            "\n",
            "**4. Surgery or interference information (if has)**\n",
            "There is no surgery or interference information available in the patient's record.\n",
            "\n",
            "Total Tokens: 1945\n",
            "Prompt Tokens: 1632\n",
            "Completion Tokens: 313\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help you answer the questions based on the patient's information.\n",
            "\n",
            "**1. Date of encounter:** \n",
            "The date of encounter is 18/07/2023.\n",
            "\n",
            "**2. Laboratory tests supporting the diagnosis:**\n",
            "The laboratory tests support the diagnosis of E78 - Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác (Disorders of lipoprotein metabolism and other lipidemias) and E11 - Bệnh đái tháo đường không phụ thuộc insuline (Non-insulin-dependent diabetes mellitus).\n",
            "\n",
            "**3. Drug information:**\n",
            "The patient is currently taking:\n",
            "- Meglucon 1000\n",
            "- Diamicron MR 60mg\n",
            "- Ezensimva 10/10\n",
            "- Sitagibes 100\n",
            "\n",
            "No drugs have been removed.\n",
            "\n",
            "**Why did the medication change?**\n",
            "There is no evidence of a medication change in this encounter.\n",
            "\n",
            "**4. Surgery or interference information:**\n",
            "There is no surgery or interference information available in this encounter.\n",
            "\n",
            "Total Tokens: 1595\n",
            "Prompt Tokens: 1386\n",
            "Completion Tokens: 209\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 15/08/2023\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "- E78: Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác (no specific lab test mentioned, but the patient is diagnosed with this condition)\n",
            "- E11: Bệnh đái tháo đường không phụ thuộc insuline (supported by the lab test: Đường mao mạch: 150, which is higher than the normal range of 70-120)\n",
            "\n",
            "**3. Drug information:**\n",
            "- Added: Dorocron MR 60 mg\n",
            "- Removed: Diamicron MR 60mg\n",
            "- Why does it change? The doctor likely changed the medication from Diamicron MR to Dorocron MR to better manage the patient's blood sugar levels, as the patient's blood glucose level is still high (150) despite being on Diamicron MR.\n",
            "- Evidence: The patient's blood glucose level is still high, indicating that the previous medication was not effective in controlling blood sugar levels.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned.\n",
            "\n",
            "Total Tokens: 562\n",
            "Prompt Tokens: 330\n",
            "Completion Tokens: 232\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help you answer the questions based on the patient's information.\n",
            "\n",
            "**1. Date of encounter**\n",
            "The date of encounter is November 21, 2023.\n",
            "\n",
            "**2. Laboratory tests supporting E78 - Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác, E11 - Bệnh đái tháo đường không phụ thuộc insuline (if has)**\n",
            "The laboratory tests supporting E78 and E11 are:\n",
            "\n",
            "* Cholesterol toàn phần: 5.45 (high)\n",
            "* Triglycerid: 2.4 (high)\n",
            "* LDL. C: 3.3 (high)\n",
            "* HbA1C: 6.5 (high)\n",
            "* Glucose: 5.7 (high)\n",
            "\n",
            "**3. Extract the drug's information (add in, remove)**\n",
            "The patient is not taking any medications currently. The medications that were removed are:\n",
            "\n",
            "* Meglucon 1000\n",
            "* Ezensimva 10/10\n",
            "* Sitagibes 100\n",
            "* Dorocron MR 60 mg\n",
            "\n",
            "**Why does it change?**\n",
            "The medications were removed likely due to the patient's current medical conditions, including diabetes and hyperlipidemia, which require adjustments to their medication regimen.\n",
            "\n",
            "**Evidence**\n",
            "The evidence for this change is based on the patient's laboratory test results, which indicate high cholesterol, triglycerides, and glucose levels, as well as a high HbA1C level, indicating poor glycemic control.\n",
            "\n",
            "**4. Surgery or interference information (if has)**\n",
            "There is no surgery or interference information available in the patient's record.\n",
            "\n",
            "Total Tokens: 1912\n",
            "Prompt Tokens: 1576\n",
            "Completion Tokens: 336\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 05/12/2023\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "- E11: Bệnh đái tháo đường không phụ thuộc insuline (Type 2 Diabetes Mellitus)\n",
            "- E78: Rối loạn chuyển hoá lipoprotein và tình trạng tăng lipid máu khác (Disorders of lipoprotein metabolism and other lipidemias) is not explicitly mentioned, but the presence of Statinagi 20 (a statin medication) suggests that the patient may have dyslipidemia.\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:**\n",
            "- Statinagi 20\n",
            "- Forclamide\n",
            "- Metformin Stada 1000 mg MR\n",
            "- Sitagibes 100\n",
            "\n",
            "**Removed:** None\n",
            "\n",
            "**Why did the medication change?**\n",
            "The medication was changed to add Statinagi 20, Forclamide, Metformin Stada 1000 mg MR, and Sitagibes 100 to manage the patient's Type 2 Diabetes Mellitus and dyslipidemia. The evidence for this change is the presence of these medications in the patient's medication list.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned.\n",
            "\n",
            "Total Tokens: 565\n",
            "Prompt Tokens: 308\n",
            "Completion Tokens: 257\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help you answer the questions based on the patient's information.\n",
            "\n",
            "**1. Date of encounter**\n",
            "The date of encounter is December 20, 2020.\n",
            "\n",
            "**2. Laboratory tests supporting R94.5 - Abnormal liver function test results**\n",
            "The laboratory tests supporting R94.5 are:\n",
            "\n",
            "* SGOT (AST): 40.4 (M: < 37; F: < 31)\n",
            "* SGPT (ALT): 93.1 (M: < 40; F: < 31)\n",
            "\n",
            "These test results indicate abnormal liver function.\n",
            "\n",
            "**3. Extracted drug information (add/remove) and reason for change**\n",
            "There is no drug information available in the patient's record, so there is no drug to add or remove.\n",
            "\n",
            "**4. Surgery or interference information (if any)**\n",
            "There is no surgery or interference information available in the patient's record.\n",
            "\n",
            "Total Tokens: 1622\n",
            "Prompt Tokens: 1439\n",
            "Completion Tokens: 183\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 05/12/2023\n",
            "\n",
            "**2. Laboratory tests supporting R94.5 - Abnormal liver function test results:** Not specified in the patient's information.\n",
            "\n",
            "**3. Drug information:**\n",
            "Added: Silygamma\n",
            "Removed: None\n",
            "\n",
            "**Why did the drug change?** The patient was prescribed Silygamma to support liver function, as indicated by the diagnosis of R94.5 - Abnormal liver function test results. **Evidence:** The patient's diagnosis and the addition of Silygamma to their medication regimen.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in the patient's information.\n",
            "\n",
            "Total Tokens: 380\n",
            "Prompt Tokens: 242\n",
            "Completion Tokens: 138\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 15/02/2022\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "I10 - Bệnh tăng huyết áp vô căn (nguyên phát) (Primary hypertension)\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Telzid 40/12.5 (a combination of telmisartan 40mg and hydrochlorothiazide 12.5mg, an antihypertensive medication)\n",
            "**No removal of medications**\n",
            "\n",
            "**Why was Telzid 40/12.5 added?**\n",
            "The patient was diagnosed with primary hypertension (I10), and Telzid 40/12.5 was prescribed to control blood pressure. The evidence is the patient's blood pressure reading of 120/80 mmHg, which is higher than normal.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned.\n",
            "\n",
            "Total Tokens: 470\n",
            "Prompt Tokens: 277\n",
            "Completion Tokens: 193\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 15/03/2022\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "I10 - Bệnh tăng huyết áp vô căn (nguyên phát) (Hypertension)\n",
            "No evidence of I83 - Dãn tĩnh mạch chi dưới (Varicose veins of lower extremities) or I25.5 - Bệnh cơ tim do thiếu máu cục bộ (Ischaemic heart disease) in this encounter.\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Valsgim 80, Biovacor\n",
            "**Removed:** Telzid 40/12.5\n",
            "\n",
            "**Why did it change?**\n",
            "The doctor likely changed the medication to better control the patient's hypertension. Telzid 40/12.5 was removed, and Valsgim 80 and Biovacor were added or continued to manage the patient's blood pressure. The evidence is the patient's blood pressure reading of 120/80 mmHg, which indicates that the previous medication regimen may not have been effective in controlling their hypertension.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in this encounter.\n",
            "\n",
            "Total Tokens: 554\n",
            "Prompt Tokens: 305\n",
            "Completion Tokens: 249\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 04/04/2022\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "I10 - Bệnh tăng huyết áp vô căn (nguyên phát) (Hypertension)\n",
            "No evidence of I83 - Dãn tĩnh mạch chi dưới (Peripheral venous insufficiency) or I25.5 - Bệnh cơ tim do thiếu máu cục bộ (Ischaemic heart disease) in this encounter.\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Nebivolol\n",
            "**Removed:** Valsgim 80, Biovacor\n",
            "\n",
            "**Why did it change?**\n",
            "The doctor likely changed the medication to better control the patient's hypertension. Nebivolol is a beta blocker that can help lower blood pressure. Valsgim 80 and Biovacor may not have been effective in controlling the patient's hypertension, so the doctor replaced them with Nebivolol.\n",
            "\n",
            "**Evidence:** The patient's blood pressure is still elevated (120/80 mmHg), indicating that the previous medications were not effective in controlling their hypertension.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in this encounter.\n",
            "\n",
            "Total Tokens: 543\n",
            "Prompt Tokens: 294\n",
            "Completion Tokens: 249\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help you answer the questions based on the patient's information.\n",
            "\n",
            "**1. Date of encounter**\n",
            "The date of encounter is 12/04/2022.\n",
            "\n",
            "**2. Laboratory tests support for I10, I83, I25.5**\n",
            "The laboratory tests support the diagnosis of:\n",
            "- I10: Bệnh tăng huyết áp vô căn (nguyên phát) - Hypertension, as evidenced by the blood pressure reading of 120/70 mmHg.\n",
            "- No laboratory tests support the diagnosis of I83 - Dãn tĩnh mạch chi dưới (Varicose veins of lower extremities) in this encounter.\n",
            "- No laboratory tests support the diagnosis of I25.5 - Bệnh cơ tim do thiếu máu cục bộ (Ischaemic heart disease) in this encounter.\n",
            "\n",
            "**3. Drug information and changes**\n",
            "The patient is currently taking:\n",
            "- Atorvastatin 20 mg\n",
            "- Tovecor 5\n",
            "- SaViProlol 2,5\n",
            "\n",
            "Changes:\n",
            "- Added: None\n",
            "- Removed: Nebivolol\n",
            "\n",
            "Why was Nebivolol removed? \n",
            "The evidence suggests that Nebivolol was removed and replaced with SaViProlol, possibly due to the need for a different beta blocker to manage the patient's hypertension.\n",
            "\n",
            "**4. Surgery or interference information**\n",
            "There is no surgery or interference information in this encounter.\n",
            "\n",
            "Total Tokens: 680\n",
            "Prompt Tokens: 388\n",
            "Completion Tokens: 292\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 10/05/2022\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "I10 - Bệnh tăng huyết áp vô căn (nguyên phát) (Primary hypertension)\n",
            "No evidence of I83 - Dãn tĩnh mạch chi dưới (Peripheral venous insufficiency) or I25.5 - Bệnh cơ tim do thiếu máu cục bộ (Ischaemic heart disease) in this encounter.\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Suritil, Betaloc Zok\n",
            "**Removed:** Atorvastatin 20 mg, Tovecor 5, SaViProlol 2,5\n",
            "\n",
            "**Why did it change?**\n",
            "The medications were changed to better manage the patient's hypertension. The addition of Suritil and Betaloc Zok suggests that the patient's blood pressure was not adequately controlled with the previous medications. The removal of Atorvastatin 20 mg, Tovecor 5, and SaViProlol 2,5 may be due to their potential interactions or ineffectiveness in controlling the patient's hypertension.\n",
            "\n",
            "**Evidence:** The patient's vital signs, particularly the blood pressure readings (120/80 mmHg), suggest that the previous medications were not effective in controlling their hypertension.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in this encounter.\n",
            "\n",
            "Total Tokens: 615\n",
            "Prompt Tokens: 319\n",
            "Completion Tokens: 296\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 07/06/2022\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "I10 - Bệnh tăng huyết áp vô căn (nguyên phát) (Primary hypertension)\n",
            "No evidence of I83 - Dãn tĩnh mạch chi dưới (Peripheral venous insufficiency) or I25.5 - Bệnh cơ tim do thiếu máu cục bộ (Ischaemic heart disease) in this encounter.\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** None\n",
            "**Removed:** Suritil, Betaloc Zok\n",
            "**Current medications:** Bisoprolol 2.5, A.T Perindopril 5, Simvastatin Savi 20\n",
            "\n",
            "**Why did the medications change?**\n",
            "The medications were changed to better control the patient's hypertension. The patient was previously taking Suritil and Betaloc Zok, but these medications were removed and replaced with Bisoprolol 2.5, A.T Perindopril 5, and Simvastatin Savi 20. This change was likely made to optimize the patient's blood pressure management.\n",
            "\n",
            "**Evidence:** The patient's blood pressure readings (120/80 mmHg) and pulse rate (70 bpm) suggest that the new medications are effective in controlling their hypertension.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in this encounter.\n",
            "\n",
            "Total Tokens: 636\n",
            "Prompt Tokens: 339\n",
            "Completion Tokens: 297\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 05/07/2022\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "I10 - Bệnh tăng huyết áp vô căn (nguyên phát) (Hypertension)\n",
            "No evidence of I83 - Dãn tĩnh mạch chi dưới (Varicose veins of lower extremities) or I25.5 - Bệnh cơ tim do thiếu máu cục bộ (Ischaemic heart disease) in this encounter.\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:**\n",
            "- Bisoprolol 2,5mg Tablets\n",
            "- Agirovastin 10\n",
            "\n",
            "**Removed:**\n",
            "- Bisoprolol 2.5\n",
            "- Simvastatin Savi 20\n",
            "\n",
            "**Why did it change?**\n",
            "The doctor likely changed the medication to optimize the treatment for hypertension. Bisoprolol 2,5mg Tablets were added to replace Bisoprolol 2.5, possibly due to a dosage adjustment. Agirovastin 10 was added to help lower cholesterol levels, which is important for managing hypertension. Simvastatin Savi 20 was removed, possibly due to concerns about interactions with other medications or side effects.\n",
            "\n",
            "**Evidence:**\n",
            "The patient's vital signs, including blood pressure (120/70 mmHg), suggest that the current medication regimen may not be effectively controlling their hypertension. The addition of Bisoprolol 2,5mg Tablets and Agirovastin 10 may help to better manage their blood pressure and cholesterol levels.\n",
            "\n",
            "**4. Surgery or interference information:**\n",
            "None mentioned in this encounter.\n",
            "\n",
            "Total Tokens: 685\n",
            "Prompt Tokens: 340\n",
            "Completion Tokens: 345\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help you answer the questions based on the patient's information.\n",
            "\n",
            "**1. Date of encounter**\n",
            "The date of encounter is August 2, 2022.\n",
            "\n",
            "**2. Laboratory tests supporting the diagnosis**\n",
            "The laboratory tests support the diagnosis of:\n",
            "- I10 - Bệnh tăng huyết áp vô căn (nguyên phát) (Essential hypertension)\n",
            "- No laboratory tests support the diagnosis of I83 - Dãn tĩnh mạch chi dưới (Varicose veins of lower extremities) or I25.5 - Bệnh cơ tim do thiếu máu cục bộ (Ischaemic heart disease).\n",
            "\n",
            "**3. Drug information**\n",
            "The patient is currently taking:\n",
            "- Bisoprolol 2.5mg Tablets\n",
            "- Ramizes 5 (added)\n",
            "\n",
            "The patient has stopped taking:\n",
            "- A.T Perindopril 5\n",
            "- Agirovastin 10\n",
            "\n",
            "**Why did the medication change?**\n",
            "The medication changed because of the patient's gastrointestinal disorder and elevated liver enzymes (SGPT/ALT: 52, GGT: 201). The doctor likely stopped A.T Perindopril 5 and Agirovastin 10 due to the patient's gastrointestinal side effects and liver enzyme abnormalities.\n",
            "\n",
            "**4. Surgery or interference information**\n",
            "There is no surgery or interference information mentioned in the patient's record.\n",
            "\n",
            "Total Tokens: 1841\n",
            "Prompt Tokens: 1558\n",
            "Completion Tokens: 283\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 30/08/2022\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "I10 - Bệnh tăng huyết áp vô căn (nguyên phát), I83 - Dãn tĩnh mạch chi dưới (no evidence of I25.5 - Bệnh cơ tim do thiếu máu cục bộ)\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Ramipril GP\n",
            "**Removed:** Ramizes 5\n",
            "**Current medications:** Bisoprolol 2,5mg Tablets, Ramipril GP\n",
            "\n",
            "**Why did it change?** \n",
            "The doctor added Ramipril GP, which is an ACE inhibitor, to help control blood pressure (I10 - Bệnh tăng huyết áp vô căn). Ramizes 5 was removed, possibly due to its potential interaction with Ramipril GP or ineffectiveness in controlling blood pressure. The evidence is based on the patient's blood pressure readings (120/80 mmHg) and the diagnosis of hypertension.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned.\n",
            "\n",
            "Total Tokens: 548\n",
            "Prompt Tokens: 312\n",
            "Completion Tokens: 236\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 27/09/2022\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "I10 - Bệnh tăng huyết áp vô căn (nguyên phát) (Hypertension)\n",
            "No evidence of I83 - Dãn tĩnh mạch chi dưới (Varicose veins of lower extremities) or I25.5 - Bệnh cơ tim do thiếu máu cục bộ (Ischaemic heart disease) in this encounter.\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Ramizes 5\n",
            "**Removed:** Ramipril GP\n",
            "**Remaining:** Bisoprolol 2,5mg Tablets, Ramizes 5\n",
            "\n",
            "**Why did it change?**\n",
            "The doctor likely removed Ramipril GP, an ACE inhibitor, and added Ramizes 5, possibly due to the patient's blood pressure (120/80 mmHg) and pulse rate (80 bpm) being within a relatively normal range. The addition of Ramizes 5 may be to further control blood pressure or for its potential benefits in cardiovascular health. The evidence for this change is based on the patient's vital signs and medication list.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in this encounter.\n",
            "\n",
            "Total Tokens: 564\n",
            "Prompt Tokens: 301\n",
            "Completion Tokens: 263\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 25/10/2022\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "I10 - Bệnh tăng huyết áp vô căn (nguyên phát) (Primary hypertension)\n",
            "No evidence of I83 - Dãn tĩnh mạch chi dưới (Peripheral venous insufficiency) or I25.5 - Bệnh cơ tim do thiếu máu cục bộ (Ischaemic heart disease) in this encounter.\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Beynit 2.5\n",
            "**Removed:** Ramizes 5\n",
            "**Current medications:** Bisoprolol 2.5mg Tablets, Beynit 2.5\n",
            "\n",
            "**Why did the medication change?**\n",
            "The medication was changed to add Beynit 2.5 and remove Ramizes 5, likely due to the patient's blood pressure management. The patient's blood pressure is 120/80 mmHg, which is still above the normal range. The addition of Beynit 2.5, an ACE inhibitor, may help to further lower the patient's blood pressure. The removal of Ramizes 5 may be due to its ineffectiveness in controlling the patient's blood pressure or potential side effects.\n",
            "\n",
            "**Evidence:** The patient's blood pressure reading of 120/80 mmHg and the addition of an ACE inhibitor (Beynit 2.5) suggest that the medication change was made to improve blood pressure control.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in this encounter.\n",
            "\n",
            "Total Tokens: 629\n",
            "Prompt Tokens: 305\n",
            "Completion Tokens: 324\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help you answer the questions based on the patient's information.\n",
            "\n",
            "**1. Date of encounter:** 22/11/2022\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "I10 - Bệnh tăng huyết áp vô căn (nguyên phát) (Hypertension)\n",
            "No evidence of I83 - Dãn tĩnh mạch chi dưới (Varicose veins of lower extremities) or I25.5 - Bệnh cơ tim do thiếu máu cục bộ (Ischaemic heart disease) in this encounter.\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Ramipril GP, Ravastel-20\n",
            "**Removed:** Bisoprolol 2,5mg Tablets, Beynit 2.5\n",
            "\n",
            "**Why did it change?**\n",
            "The medications were changed likely due to the patient's elevated liver enzymes (Tăng men gan) and Gastroesophageal reflux disease (GERD). Ramipril GP is an ACE inhibitor that can help lower blood pressure, while Ravastel-20 is a statin that can help manage cholesterol levels. Bisoprolol, a beta blocker, was removed, possibly due to its potential to exacerbate GERD symptoms. Beynit 2.5 was also removed, but the reason is not explicitly stated in the patient's information.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in this encounter.\n",
            "\n",
            "Total Tokens: 616\n",
            "Prompt Tokens: 323\n",
            "Completion Tokens: 293\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help you with the patient's information.\n",
            "\n",
            "**1. Date of encounter:** 08/12/2022\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "- I10: Bệnh tăng huyết áp vô căn (nguyên phát) - supported by blood pressure readings (140/80 mmHg)\n",
            "- No evidence of I83: Dãn tĩnh mạch chi dưới\n",
            "- No evidence of I25.5: Bệnh cơ tim do thiếu máu cục bộ\n",
            "\n",
            "**3. Drug information:**\n",
            "- Removed: Ramipril GP, Ravastel-20\n",
            "- No new medications added\n",
            "\n",
            "**Why did it change?**\n",
            "The medications were removed, likely due to the patient's current health status and laboratory results. The doctor may have decided to stop these medications to adjust the treatment plan.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in the patient's information.\n",
            "\n",
            "Total Tokens: 1835\n",
            "Prompt Tokens: 1642\n",
            "Completion Tokens: 193\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 15/08/2023\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "- I10: Bệnh tăng huyết áp vô căn (nguyên phát) - supported by blood pressure readings (120/80 mmHg)\n",
            "- No evidence of I83 (Dãn tĩnh mạch chi dưới) or I25.5 (Bệnh cơ tim do thiếu máu cục bộ) in this encounter.\n",
            "\n",
            "**3. Drug information:**\n",
            "- Added: Nebilet, Ramipril GP\n",
            "- Removed: None\n",
            "- Reason for change: The patient was diagnosed with hypertension (I10), and the doctor prescribed Nebilet and Ramipril GP to control blood pressure. The evidence is the patient's blood pressure readings (120/80 mmHg) and the diagnosis of hypertension.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in this encounter.\n",
            "\n",
            "Total Tokens: 501\n",
            "Prompt Tokens: 305\n",
            "Completion Tokens: 196\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help you with the patient's information.\n",
            "\n",
            "**1. Date of encounter:** 21/11/2023\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "- I10 - Bệnh tăng huyết áp vô căn (nguyên phát) (Hypertension)\n",
            "- No evidence of I83 - Dãn tĩnh mạch chi dưới (Varicose veins of lower extremities) or I25.5 - Bệnh cơ tim do thiếu máu cục bộ (Ischaemic heart disease)\n",
            "\n",
            "**3. Drug information:**\n",
            "- Removed: Nebilet, Ramipril GP\n",
            "- No new medications added\n",
            "\n",
            "**Why did it change?**\n",
            "The medications Nebilet and Ramipril GP were removed, likely due to the patient's current medical conditions and laboratory results. The patient has hypertension, type II diabetes, high cholesterol, and liver enzyme abnormalities, which may require adjustments to their medication regimen.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in the patient's information.\n",
            "\n",
            "Total Tokens: 1765\n",
            "Prompt Tokens: 1553\n",
            "Completion Tokens: 212\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 05/12/2023\n",
            "\n",
            "**2. Laboratory tests support for:**\n",
            "I10 - Bệnh tăng huyết áp vô căn (nguyên phát) - supported by blood pressure readings (120/70 mmHg)\n",
            "I25.5 - Bệnh cơ tim do thiếu máu cục bộ - no specific laboratory test mentioned, but the diagnosis is based on clinical evaluation\n",
            "No mention of I83 - Dãn tĩnh mạch chi dưới, so no laboratory test support for this diagnosis\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Statinagi 20, Mibetel HCT (both were already prescribed, no new additions)\n",
            "**Removed:** None\n",
            "**Why did it change?** There is no change in medication, as the same medications were already prescribed and no new medications were added or removed. **Evidence:** The \"Thêm\" (added) section only lists the same medications already prescribed, and the \"Bỏ\" (removed) section is empty.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned.\n",
            "\n",
            "Total Tokens: 545\n",
            "Prompt Tokens: 313\n",
            "Completion Tokens: 232\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 04/04/2022\n",
            "\n",
            "**2. Laboratory tests support:** None mentioned in the patient's information.\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Omeprazol 20mg, Varogel\n",
            "**Removed:** None\n",
            "**Why does it change?** The patient was diagnosed with K29 - Viêm dạ dày và tá tràng (Gastritis and Duodenitis), and Omeprazol 20mg and Varogel were prescribed to treat the condition. Omeprazol is a proton pump inhibitor that reduces stomach acid production, and Varogel is an antacid that helps neutralize stomach acid. **Evidence:** The patient's diagnosis and the medications prescribed.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in the patient's information.\n",
            "\n",
            "Total Tokens: 420\n",
            "Prompt Tokens: 243\n",
            "Completion Tokens: 177\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 12/04/2022\n",
            "\n",
            "**2. Laboratory tests support for K29 - Viêm dạ dày và tá tràng, K58 - Hội chứng ruột kích thích (if has):**\n",
            "No laboratory tests support for K58 - Hội chứng ruột kích thích. However, the laboratory tests support for K29 - Viêm dạ dày và tá tràng are not explicitly stated, but the diagnosis is made based on clinical evaluation.\n",
            "\n",
            "**3. Extract the drug's information (add in, remove):**\n",
            "Added: Sipantoz 20\n",
            "Removed: Omeprazol 20mg, Varogel\n",
            "\n",
            "**Why does it change?**\n",
            "The medication change is likely due to the diagnosis of K29 - Viêm dạ dày và tá tràng, which requires a different treatment approach. Sipantoz 20 was added, possibly to reduce gastric acid secretion and alleviate symptoms of gastritis. Omeprazol 20mg, a proton pump inhibitor, was removed, possibly due to its potential interactions or ineffectiveness in this patient. Varogel was also removed, possibly due to its limited efficacy in this patient's condition.\n",
            "\n",
            "**Evidence (based on the patient's information):**\n",
            "The diagnosis of K29 - Viêm dạ dày và tá tràng and the addition of Sipantoz 20 support this change.\n",
            "\n",
            "**4. Surgery or interference information (if has):**\n",
            "None mentioned.\n",
            "\n",
            "Total Tokens: 632\n",
            "Prompt Tokens: 324\n",
            "Completion Tokens: 308\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 10/05/2022\n",
            "\n",
            "**2. Laboratory tests support:** \n",
            "The patient has been diagnosed with K29 - Viêm dạ dày và tá tràng (Gastritis and Duodenitis). There is no evidence of K58 - Hội chứng ruột kích thích (Irritable Bowel Syndrome) in this encounter.\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Dogastrol, Bisnol\n",
            "**Removed:** Sipantoz 20\n",
            "\n",
            "**Why did it change?**\n",
            "The doctor has added Dogastrol and Bisnol to the patient's medication regimen, likely to treat the patient's gastritis and duodenitis. Sipantoz 20 was removed, possibly due to its ineffectiveness or side effects.\n",
            "\n",
            "**Evidence:** The patient's diagnosis of gastritis and duodenitis, and the addition of medications that are commonly used to treat these conditions.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in this encounter.\n",
            "\n",
            "Total Tokens: 472\n",
            "Prompt Tokens: 260\n",
            "Completion Tokens: 212\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 07/06/2022\n",
            "\n",
            "**2. Laboratory tests support:** \n",
            "The patient has been diagnosed with K29 - Viêm dạ dày và tá tràng (Gastritis and Duodenitis). There is no evidence of K58 - Hội chứng ruột kích thích (Irritable Bowel Syndrome) in this encounter.\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Omeprazol 20mg\n",
            "**Removed:** Dogastrol\n",
            "**Reason for change:** The patient was prescribed Omeprazol 20mg, which is a proton pump inhibitor (PPI) commonly used to treat gastritis and duodenitis. Dogastrol was removed, possibly due to its ineffectiveness or side effects. The evidence for this change is based on the patient's diagnosis of gastritis and duodenitis, which requires treatment with a PPI like Omeprazol.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in this encounter.\n",
            "\n",
            "Total Tokens: 476\n",
            "Prompt Tokens: 263\n",
            "Completion Tokens: 213\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 05/07/2022\n",
            "\n",
            "**2. Laboratory tests support:** None mentioned in the patient's information. However, the diagnosis is K58 - Hội chứng ruột kích thích (Irritable Bowel Syndrome).\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** L-BIO-3D, Agitritine 200\n",
            "**Removed:** Omeprazol 20mg, Bisnol\n",
            "\n",
            "**Why did it change?** The patient was likely experiencing gastrointestinal symptoms, and the doctor decided to remove Omeprazol (a proton pump inhibitor) and Bisnol, which may not have been effective in managing the patient's symptoms. L-BIO-3D and Agitritine 200 were added to the treatment regimen to better manage the patient's Irritable Bowel Syndrome (K58).\n",
            "\n",
            "**Evidence:** The patient's diagnosis of K58 - Hội chứng ruột kích thích (Irritable Bowel Syndrome) and the addition of L-BIO-3D and Agitritine 200, which are likely medications used to manage IBS symptoms.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in the patient's information.\n",
            "\n",
            "Total Tokens: 528\n",
            "Prompt Tokens: 275\n",
            "Completion Tokens: 253\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help you answer the questions based on the patient's information.\n",
            "\n",
            "**1. Date of encounter**\n",
            "The date of encounter is August 2, 2022.\n",
            "\n",
            "**2. Laboratory tests supporting K29 - Viêm dạ dày và tá tràng, K58 - Hội chứng ruột kích thích (if has)**\n",
            "The laboratory tests supporting the diagnosis of K29 - Viêm dạ dày và tá tràng (Gastritis and Duodenitis) include:\n",
            "\n",
            "* Elevated SGPT (ALT) level: 52 (normal range: 0-45)\n",
            "* Elevated GGT level: 201 (normal range: 11-50)\n",
            "* Elevated Triglycerid level: 3.3 (normal range: 0.46-1.88)\n",
            "\n",
            "These test results indicate liver enzyme abnormalities, which are consistent with gastritis and duodenitis.\n",
            "\n",
            "**3. Extract the drug's information (add in, remove)**\n",
            "The patient is currently taking:\n",
            "\n",
            "* Rabeprazol 20\n",
            "* Agitritine 200\n",
            "\n",
            "The following medication has been added:\n",
            "\n",
            "* Rabeprazol 20\n",
            "\n",
            "The following medication has been removed:\n",
            "\n",
            "* L-BIO-3D\n",
            "\n",
            "**Why does it change?**\n",
            "The medication change is likely due to the patient's diagnosis of gastritis and duodenitis, which requires treatment with proton pump inhibitors (PPIs) such as Rabeprazol to reduce acid production in the stomach. The addition of Rabeprazol 20 and removal of L-BIO-3D may be related to the patient's response to treatment and the need for further acid suppression.\n",
            "\n",
            "**4. Surgery or interference information (if has)**\n",
            "There is no surgery or interference information mentioned in the patient's record.\n",
            "\n",
            "Total Tokens: 1878\n",
            "Prompt Tokens: 1512\n",
            "Completion Tokens: 366\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 30/08/2022\n",
            "\n",
            "**2. Laboratory tests support:** \n",
            "The patient has been diagnosed with K29 - Viêm dạ dày và tá tràng (Gastritis and Duodenitis). There is no evidence of K58 - Hội chứng ruột kích thích (Irritable Bowel Syndrome) in this encounter.\n",
            "\n",
            "**3. Drug information:**\n",
            "The patient is currently taking:\n",
            "* Martaz\n",
            "* Agitritine 200\n",
            "\n",
            "Added:\n",
            "* Martaz\n",
            "\n",
            "Removed:\n",
            "* Rabeprazol 20\n",
            "\n",
            "**Why did the medication change?**\n",
            "The medication was changed because the patient's condition, gastritis and duodenitis, requires a different treatment approach. Rabeprazol, a proton pump inhibitor, was likely removed because it may not be effective in treating the patient's current condition. Martaz was added to the treatment regimen, possibly to help manage the patient's symptoms.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in this encounter.\n",
            "\n",
            "Total Tokens: 474\n",
            "Prompt Tokens: 258\n",
            "Completion Tokens: 216\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 27/09/2022\n",
            "\n",
            "**2. Laboratory tests support:** \n",
            "The patient has been diagnosed with K29 - Viêm dạ dày và tá tràng (Gastritis and Duodenitis). There is no evidence of K58 - Hội chứng ruột kích thích (Irritable Bowel Syndrome) in this encounter.\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Meburatin tablet 150mg\n",
            "**Removed:** Agitritine 200\n",
            "**Reason for change:** The doctor has added Meburatin tablet 150mg to the patient's medication regimen, possibly to treat the gastritis and duodenitis. Agitritine 200 has been removed, possibly due to its ineffectiveness or side effects. The evidence for this change is based on the patient's diagnosis of gastritis and duodenitis, which requires a different treatment approach.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in this encounter.\n",
            "\n",
            "Total Tokens: 470\n",
            "Prompt Tokens: 263\n",
            "Completion Tokens: 207\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 25/10/2022\n",
            "\n",
            "**2. Laboratory tests support:** \n",
            "The patient has been diagnosed with K29 - Viêm dạ dày và tá tràng (Gastritis and Duodenitis). There is no evidence of K58 - Hội chứng ruột kích thích (Irritable Bowel Syndrome) in this encounter.\n",
            "\n",
            "**3. Drug information:**\n",
            "**Added:** Dogastrol 40 mg, L-BIO-3D\n",
            "**Removed:** Martaz, Meburatin tablet 150mg\n",
            "\n",
            "**Why did the medication change?**\n",
            "The medication was changed to treat the patient's gastritis and duodenitis. Dogastrol 40 mg is a proton pump inhibitor that reduces acid production in the stomach, which can help alleviate symptoms of gastritis. L-BIO-3D is a probiotic that can help maintain a healthy gut microbiome. Martaz and Meburatin tablet 150mg were likely removed because they were not effective in treating the patient's condition or had adverse effects.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned in this encounter.\n",
            "\n",
            "Total Tokens: 512\n",
            "Prompt Tokens: 276\n",
            "Completion Tokens: 236\n",
            "Total Cost (USD): $0.0\n",
            "I'd be happy to help!\n",
            "\n",
            "**1. Date of encounter:** 22/11/2022\n",
            "\n",
            "**2. Laboratory tests support:** \n",
            "- K58 - Hội chứng ruột kích thích (Irritable Bowel Syndrome)\n",
            "- There is no specific laboratory test mentioned, but the note mentions \"Tăng men gan\" which suggests elevated liver enzymes, possibly indicating liver dysfunction.\n",
            "\n",
            "**3. Drug information:**\n",
            "- Added: Verimed 135mg\n",
            "- Removed: L-BIO-3D\n",
            "- Continued: Dogastrol 40 mg, Verimed 135mg\n",
            "\n",
            "**Why did it change?**\n",
            "The medication was changed because the patient's condition, Irritable Bowel Syndrome (K58), requires a different treatment approach. The addition of Verimed 135mg and removal of L-BIO-3D suggest that the doctor is trying to manage the patient's symptoms more effectively. The continued use of Dogastrol 40 mg and Verimed 135mg implies that these medications are still necessary for the patient's treatment.\n",
            "\n",
            "**4. Surgery or interference information:** None mentioned.\n",
            "\n",
            "Total Tokens: 493\n",
            "Prompt Tokens: 269\n",
            "Completion Tokens: 224\n",
            "Total Cost (USD): $0.0\n"
          ]
        }
      ],
      "source": [
        "summary_group = {}\n",
        "for name_group in context_event[0].format.keys():\n",
        "  summary = \"\"\n",
        "  for i in context_enc[name_group]:\n",
        "    with get_openai_callback() as cb:\n",
        "      output = chain_abstract.predict(key_group = name_group,diags = \", \".join(context_event[0].format[name_group]),patient_inf = i)\n",
        "      summary += output\n",
        "      print(output)\n",
        "      print()\n",
        "      print(f\"Total Tokens: {cb.total_tokens}\")\n",
        "      print(f\"Prompt Tokens: {cb.prompt_tokens}\")\n",
        "      print(f\"Completion Tokens: {cb.completion_tokens}\")\n",
        "      print(f\"Total Cost (USD): ${cb.total_cost}\")\n",
        "      cost += cb.total_cost\n",
        "  summary_group[name_group] = summary"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "IaGOZ0giYkD2"
      },
      "outputs": [],
      "source": [
        "#prompt for summary all enc\n",
        "prompt_sum = PromptTemplate(\n",
        "    template = \"\"\"The following is set of encounter overtime. Each encounter begins with date of encounter.\n",
        "    The encounter is for treating {diags}\n",
        "Information encounter over time:\n",
        "{text}\n",
        "\n",
        "Please healp me summarize all encounter. The summary inlcude the following information:\n",
        "1. The group of diagnosis is {group_name}\n",
        "2. The big changing of the patient.\n",
        "  -Changing in drug or Diagnosis (if has)\n",
        "  -Show the drug's change with 3 parts: regularly used drug, Stop drug (Drug only used one time in the past), replaced drug (drugs replace each other)\n",
        "  -Give the reason for changing drug (if you think the reason is the big issue)\n",
        "3. Note of doctor about the patient (if has)\n",
        "4. Conclusion about state of patient\n",
        "Ouput in Vietnamese. Do not show detail summary over date.\n",
        "Now take a deep breath, then analyze and give me the summary\n",
        "Helpful Answer:\n",
        "     \"\"\",\n",
        "    input_variables=[\"text\",'diags','group_name']\n",
        ")\n",
        "chain_sum = LLMChain(prompt = prompt_sum,\n",
        "                 llm = chat_4)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "UdXdpuvhYo9b",
        "outputId": "feb5fcfe-72f8-4c9b-c0c2-3460f5e2ecdb"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "**Tóm tắt các lần gặp gỡ bệnh nhân:**\n",
            "\n",
            "1. **Nhóm chẩn đoán:** Rối loạn chuyển hóa\n",
            "\n",
            "2. **Những thay đổi lớn của bệnh nhân:**\n",
            "   - **Thay đổi trong thuốc hoặc chẩn đoán:**\n",
            "     - **Thuốc sử dụng thường xuyên:**\n",
            "       - Glucophage XR 500 mg\n",
            "       - Metformin 500 mg\n",
            "       - Simvastatin Savi 20\n",
            "       - Sitagibes 50\n",
            "       - Fenostad 200\n",
            "       - Meglucon 1000\n",
            "       - Diamicron MR 60 mg\n",
            "       - Ezensimva 10/10\n",
            "       - Sitagibes 100\n",
            "       - Statinagi 20\n",
            "       - Forclamide\n",
            "       - Metformin Stada 1000 mg MR\n",
            "\n",
            "     - **Thuốc đã ngừng (chỉ sử dụng một lần trong quá khứ):**\n",
            "       - Stazemid 20/10\n",
            "       - Biovacor\n",
            "       - Atorvastatin 20 mg\n",
            "       - Glucophage 500 mg\n",
            "       - Simvastar tablet 20 mg\n",
            "       - Agirovastin 10\n",
            "       - Galvus\n",
            "       - SaVi Bezafibrate 200\n",
            "       - Meyersiliptin 25\n",
            "       - Lipagim 200\n",
            "       - Flodilan - 2\n",
            "       - Ravastel-20\n",
            "       - Ramipril GP\n",
            "       - Dorocron MR 60 mg\n",
            "\n",
            "     - **Thuốc thay thế nhau:**\n",
            "       - Glucophage XR 500 mg -> Glucophage 500 mg -> Metformin 500 mg -> Metformin Stada 1000 mg MR\n",
            "       - Stazemid 20/10 -> Biovacor -> Atorvastatin 20 mg -> Simvastar tablet 20 mg -> Simvastatin Savi 20 -> Agirovastin 10 -> SaVi Bezafibrate 200 -> Lipagim 200 -> Fenostad 200 -> Ravastel-20 -> Statinagi 20\n",
            "       - Diamicron MR 60 mg -> Dorocron MR 60 mg -> Forclamide\n",
            "       - Sitagibes 50 -> Sitagibes 100\n",
            "\n",
            "   - **Lý do thay đổi thuốc:**\n",
            "     - Các thay đổi thuốc chủ yếu nhằm cải thiện kiểm soát đường huyết và hồ sơ lipid của bệnh nhân. Các thuốc như Metformin, Glucophage, và Sitagibes được sử dụng để quản lý bệnh đái tháo đường không phụ thuộc insuline (E11). Các thuốc như Simvastatin, Atorvastatin, và Fenostad được sử dụng để quản lý rối loạn chuyển hóa lipoprotein và tình trạng tăng lipid máu khác (E78). Các thay đổi thuốc có thể do hiệu quả điều trị không đạt yêu cầu hoặc do tác dụng phụ của thuốc.\n",
            "\n",
            "3. **Ghi chú của bác sĩ về bệnh nhân:**\n",
            "   - Không có ghi chú cụ thể của bác sĩ được đề cập trong hồ sơ bệnh nhân.\n",
            "\n",
            "4. **Kết luận về tình trạng của bệnh nhân:**\n",
            "   - Bệnh nhân đang được điều trị cho các rối loạn chuyển hóa, bao gồm rối loạn chuyển hóa lipoprotein và tình trạng tăng lipid máu khác (E78) và bệnh đái tháo đường không phụ thuộc insuline (E11). Các thay đổi thuốc thường xuyên nhằm mục đích tối ưu hóa kiểm soát đường huyết và hồ sơ lipid của bệnh nhân. Tình trạng của bệnh nhân cần được theo dõi liên tục và điều chỉnh thuốc phù hợp để đạt hiệu quả điều trị tốt nhất.\n",
            "Total Tokens: 5655\n",
            "Prompt Tokens: 4882\n",
            "Completion Tokens: 773\n",
            "Total Cost (USD): $0.036004999999999995\n",
            "------------------------------------\n",
            "\n",
            "**Tóm tắt các lần gặp gỡ bệnh nhân:**\n",
            "\n",
            "1. **Nhóm chẩn đoán:** Bất thường chức năng gan\n",
            "\n",
            "2. **Thay đổi lớn của bệnh nhân:**\n",
            "   - **Thay đổi về thuốc hoặc chẩn đoán:**\n",
            "     - **Thuốc sử dụng thường xuyên:** Silygamma\n",
            "     - **Thuốc ngừng sử dụng:** Không có\n",
            "     - **Thuốc thay thế:** Không có\n",
            "   - **Lý do thay đổi thuốc:** Bệnh nhân được kê đơn Silygamma để hỗ trợ chức năng gan, dựa trên chẩn đoán R94.5 - Kết quả bất thường về thăm dò chức năng gan.\n",
            "\n",
            "3. **Ghi chú của bác sĩ về bệnh nhân:** Không có ghi chú cụ thể từ bác sĩ trong thông tin bệnh nhân.\n",
            "\n",
            "4. **Kết luận về tình trạng của bệnh nhân:** Bệnh nhân có kết quả xét nghiệm chức năng gan bất thường và đã được kê đơn Silygamma để hỗ trợ chức năng gan. Không có thông tin về phẫu thuật hoặc can thiệp y tế khác.\n",
            "Total Tokens: 755\n",
            "Prompt Tokens: 523\n",
            "Completion Tokens: 232\n",
            "Total Cost (USD): $0.006095\n",
            "------------------------------------\n",
            "\n",
            "**Tóm tắt các lần gặp gỡ bệnh nhân:**\n",
            "\n",
            "1. **Nhóm chẩn đoán:** Bệnh tim mạch (Cardiovascular Diseases)\n",
            "\n",
            "2. **Những thay đổi lớn của bệnh nhân:**\n",
            "   - **Thay đổi về thuốc hoặc chẩn đoán:**\n",
            "     - **Thuốc sử dụng thường xuyên:**\n",
            "       - Bisoprolol 2.5mg Tablets\n",
            "       - Ramipril GP\n",
            "       - Statinagi 20\n",
            "       - Mibetel HCT\n",
            "     - **Thuốc đã ngừng sử dụng (chỉ sử dụng một lần trong quá khứ):**\n",
            "       - Telzid 40/12.5\n",
            "       - Valsgim 80\n",
            "       - Biovacor\n",
            "       - Nebivolol\n",
            "       - Atorvastatin 20 mg\n",
            "       - Tovecor 5\n",
            "       - SaViProlol 2.5\n",
            "       - Suritil\n",
            "       - Betaloc Zok\n",
            "       - Simvastatin Savi 20\n",
            "       - Agirovastin 10\n",
            "       - Ravastel-20\n",
            "       - Beynit 2.5\n",
            "       - Nebilet\n",
            "     - **Thuốc thay thế nhau:**\n",
            "       - Telzid 40/12.5 được thay thế bởi Valsgim 80 và Biovacor\n",
            "       - Valsgim 80 và Biovacor được thay thế bởi Nebivolol\n",
            "       - Nebivolol được thay thế bởi SaViProlol 2.5\n",
            "       - SaViProlol 2.5 được thay thế bởi Suritil và Betaloc Zok\n",
            "       - Suritil và Betaloc Zok được thay thế bởi Bisoprolol 2.5, A.T Perindopril 5, và Simvastatin Savi 20\n",
            "       - Simvastatin Savi 20 được thay thế bởi Agirovastin 10\n",
            "       - A.T Perindopril 5 và Agirovastin 10 được thay thế bởi Ramizes 5\n",
            "       - Ramizes 5 được thay thế bởi Ramipril GP\n",
            "       - Ramipril GP được thay thế bởi Ramizes 5\n",
            "       - Ramizes 5 được thay thế bởi Beynit 2.5\n",
            "       - Beynit 2.5 được thay thế bởi Ramipril GP và Ravastel-20\n",
            "       - Ramipril GP và Ravastel-20 được thay thế bởi Nebilet và Ramipril GP\n",
            "       - Nebilet và Ramipril GP được thay thế bởi Statinagi 20 và Mibetel HCT\n",
            "\n",
            "   - **Lý do thay đổi thuốc:**\n",
            "     - Các thay đổi thuốc chủ yếu nhằm kiểm soát huyết áp của bệnh nhân (I10 - Bệnh tăng huyết áp vô căn) và quản lý các vấn đề liên quan đến tim mạch. Một số thay đổi thuốc có thể do tác dụng phụ hoặc tương tác thuốc không mong muốn, ví dụ như tăng men gan và bệnh trào ngược dạ dày thực quản (GERD).\n",
            "\n",
            "3. **Ghi chú của bác sĩ về bệnh nhân:**\n",
            "   - Bệnh nhân có các vấn đề về men gan tăng cao và bệnh trào ngược dạ dày thực quản (GERD), điều này có thể ảnh hưởng đến việc lựa chọn thuốc.\n",
            "\n",
            "4. **Kết luận về tình trạng của bệnh nhân:**\n",
            "   - Bệnh nhân đang được điều trị và quản lý tốt các vấn đề về huyết áp và tim mạch. Các thay đổi thuốc đã được thực hiện để tối ưu hóa việc kiểm soát huyết áp và giảm thiểu các tác dụng phụ không mong muốn. Huyết áp của bệnh nhân hiện tại ổn định ở mức 120/80 mmHg, cho thấy các biện pháp điều trị đang có hiệu quả.\n",
            "Total Tokens: 5177\n",
            "Prompt Tokens: 4356\n",
            "Completion Tokens: 821\n",
            "Total Cost (USD): $0.034095\n",
            "------------------------------------\n",
            "\n",
            "**Tóm tắt các lần gặp gỡ bệnh nhân:**\n",
            "\n",
            "1. **Nhóm chẩn đoán:** Rối loạn tiêu hóa\n",
            "\n",
            "2. **Những thay đổi lớn của bệnh nhân:**\n",
            "   - **Thay đổi trong thuốc hoặc chẩn đoán:**\n",
            "     - **Thuốc sử dụng thường xuyên:**\n",
            "       - Omeprazol 20mg\n",
            "       - Sipantoz 20\n",
            "       - Dogastrol\n",
            "       - Bisnol\n",
            "       - Agitritine 200\n",
            "       - L-BIO-3D\n",
            "       - Rabeprazol 20\n",
            "       - Martaz\n",
            "       - Meburatin tablet 150mg\n",
            "       - Verimed 135mg\n",
            "     - **Thuốc đã ngừng sử dụng (chỉ sử dụng một lần trong quá khứ):**\n",
            "       - Varogel\n",
            "     - **Thuốc thay thế nhau:**\n",
            "       - Omeprazol 20mg ↔ Sipantoz 20 ↔ Dogastrol ↔ Rabeprazol 20 ↔ Martaz ↔ Dogastrol 40 mg\n",
            "       - Bisnol ↔ Agitritine 200 ↔ Meburatin tablet 150mg ↔ Verimed 135mg\n",
            "       - L-BIO-3D ↔ Verimed 135mg\n",
            "\n",
            "   - **Lý do thay đổi thuốc:**\n",
            "     - Các thay đổi thuốc chủ yếu do hiệu quả điều trị và tác dụng phụ của thuốc. Ví dụ, Omeprazol 20mg và Varogel ban đầu được sử dụng để điều trị viêm dạ dày và tá tràng, nhưng sau đó được thay thế bởi Sipantoz 20 do hiệu quả hoặc tác dụng phụ. Tương tự, các thuốc khác như Dogastrol, Rabeprazol, và Martaz cũng được thay đổi để tìm ra phương pháp điều trị hiệu quả nhất cho bệnh nhân.\n",
            "\n",
            "3. **Ghi chú của bác sĩ về bệnh nhân:**\n",
            "   - Không có ghi chú cụ thể của bác sĩ được đề cập trong thông tin bệnh nhân.\n",
            "\n",
            "4. **Kết luận về tình trạng của bệnh nhân:**\n",
            "   - Bệnh nhân được chẩn đoán với các rối loạn tiêu hóa, bao gồm viêm dạ dày và tá tràng (K29) và hội chứng ruột kích thích (K58). Các thay đổi trong thuốc điều trị cho thấy bác sĩ đang cố gắng tìm ra phương pháp điều trị hiệu quả nhất cho bệnh nhân, dựa trên phản ứng của bệnh nhân với các loại thuốc khác nhau. Tình trạng của bệnh nhân có vẻ phức tạp và cần theo dõi và điều chỉnh điều trị liên tục để đạt được hiệu quả tốt nhất.\n",
            "Total Tokens: 3138\n",
            "Prompt Tokens: 2572\n",
            "Completion Tokens: 566\n",
            "Total Cost (USD): $0.02135\n",
            "------------------------------------\n",
            "\n"
          ]
        }
      ],
      "source": [
        "for name_group in summary_group.keys():\n",
        "  with get_openai_callback() as cb:\n",
        "    output_last = chain_sum.predict(text = summary_group[name_group],diags = \", \".join(context_event[0].format[name_group]),group_name = name_group)\n",
        "    print(output_last)\n",
        "    print(f\"Total Tokens: {cb.total_tokens}\")\n",
        "    print(f\"Prompt Tokens: {cb.prompt_tokens}\")\n",
        "    print(f\"Completion Tokens: {cb.completion_tokens}\")\n",
        "    print(f\"Total Cost (USD): ${cb.total_cost}\")\n",
        "    print('------------------------------------')\n",
        "    print()\n",
        "    cost += cb.total_cost"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "onPaS_vN43CW",
        "outputId": "d8056d2f-30de-4934-c130-248e2ccd8d9c"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "0.422145"
            ]
          },
          "execution_count": 77,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "cost"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "MuzQDNnEo1iG"
      },
      "source": [
        "#Chạy từ cell này"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "e6kDscKgo3vL"
      },
      "outputs": [],
      "source": [
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns\n",
        "import pandas as pd\n",
        "from datetime import datetime\n",
        "sns.set()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "TnowrocRUi9z",
        "outputId": "4ab93c71-ae7e-4cee-e646-6d6f397a4d82"
      },
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/langchain_core/_api/deprecation.py:119: LangChainDeprecationWarning: The class `LLMChain` was deprecated in LangChain 0.1.17 and will be removed in 0.3.0. Use RunnableSequence, e.g., `prompt | llm` instead.\n",
            "  warn_deprecated(\n"
          ]
        }
      ],
      "source": [
        "#prompt for each enc\n",
        "prompt = PromptTemplate(\n",
        "    template = \"\"\"You are a sql authorized database, please help me detecting question querries, which are potential harmful sql database.\n",
        "    If the question do not mention of people, the question is only relating to the authorized people\n",
        "    For detecting, follow sequential steps:\n",
        "    1. Extract the main purpose of the querry (include action, people relating)\n",
        "    2. If the main purpose is relating to extracting constructure's database (name table, relationship, table attribute,...), return violated\n",
        "    3. If the main purpose mentions any specific people other than the authorized person, return violated\n",
        "\n",
        "  if the main purpose violate any steps, output is True. If not, output is False\n",
        "  You should only respond with True or False. Absolutely no other information should be provided\n",
        "  Take a deep breath, think step by step, and then analyze the following question querry\n",
        "  Question: {patient_inf}\n",
        "     \"\"\",\n",
        "    input_variables=[\"patient_inf\"]\n",
        ")\n",
        "memory_cons = ConversationBufferMemory(memory_key=\"chat_history\", input_key=\"patient_inf\",)\n",
        "chain = LLMChain(prompt = prompt,\n",
        "                 llm = chat_4,)\n",
        "                 #memory = memory_cons)\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "llf7Dt06UrKz"
      },
      "source": [
        "You should only respond with True or False. Absolutely no other information should be provided"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "AjF2I8QXvEY2"
      },
      "source": [
        "**Thay đổi câu hỏi ở đây!**"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "collapsed": true,
        "id": "90cmtI5yXjM-",
        "outputId": "390efd5c-d8af-4fd0-c131-4dc4be7db88d"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "question here:select Id from patient_table\n",
            "True\n",
            "\n",
            "total_token: 195\n",
            "total_cost: 0.000985\n",
            "question here:show tables;\n",
            "True\n",
            "\n",
            "total_token: 192\n",
            "total_cost: 0.00097\n",
            "question here:end\n"
          ]
        }
      ],
      "source": [
        "while True:\n",
        "  input_human = input('question here:')\n",
        "  if input_human == 'end':\n",
        "    break\n",
        "  with get_openai_callback() as cb:\n",
        "    result = chain.predict(patient_inf = input_human, return_only_outputs=True)\n",
        "    print(result)\n",
        "    print()\n",
        "    print('total_token:',cb.total_tokens)\n",
        "    print('total_cost:',cb.total_cost)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "collapsed": true,
        "id": "X2-a5HC8ZPIF",
        "outputId": "122d973a-2504-4eef-e42a-e7541fe8d56c"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Human: huyết áp của tôi là 130/90 là cao hay thấp?\n",
            "AI: Huyết áp của bạn là 130/90 mmHg được xem là cao hơn mức bình thường. Theo hướng dẫn của Hiệp hội Tim mạch Hoa Kỳ (AHA), huyết áp bình thường là dưới 120/80 mmHg. Huyết áp của bạn nằm trong khoảng tiền tăng huyết áp (prehypertension) hoặc tăng huyết áp giai đoạn 1.\n",
            "\n",
            "Bạn có thể cho tôi biết thêm về các triệu chứng khác mà bạn có thể gặp phải hoặc tiền sử bệnh lý của bạn để tôi có thể tư vấn cụ thể hơn không?\n",
            "Human: vậy tôi nên làm gì để giảm huyết áp?\n",
            "AI: Để giảm huyết áp, bạn có thể thực hiện một số biện pháp sau:\n",
            "\n",
            "1. **Thay đổi lối sống và chế độ ăn uống:**\n",
            "   - **Giảm muối:** Hạn chế lượng muối trong khẩu phần ăn hàng ngày.\n",
            "   - **Ăn nhiều rau quả và thực phẩm giàu kali:** Các loại rau xanh, trái cây, và thực phẩm giàu kali như chuối, khoai tây, và cam.\n",
            "   - **Giảm tiêu thụ chất béo bão hòa và cholesterol:** Hạn chế ăn các loại thực phẩm chiên, nướng, và các sản phẩm từ sữa có hàm lượng chất béo cao.\n",
            "   - **Uống đủ nước:** Đảm bảo uống đủ lượng nước hàng ngày.\n",
            "\n",
            "2. **Tập thể dục đều đặn:**\n",
            "   - Tập thể dục ít nhất 30 phút mỗi ngày, ít nhất 5 ngày trong tuần. Các hoạt động như đi bộ, chạy bộ, bơi lội, hoặc đạp xe đều rất tốt.\n",
            "\n",
            "3. **Giảm cân nếu bạn thừa cân:**\n",
            "   - Giảm cân có thể giúp giảm huyết áp một cách đáng kể.\n",
            "\n",
            "4. **Hạn chế rượu và thuốc lá:**\n",
            "   - Hạn chế uống rượu và tránh hút thuốc lá.\n",
            "\n",
            "5. **Quản lý căng thẳng:**\n",
            "   - Thực hiện các kỹ thuật thư giãn như yoga, thiền, hoặc hít thở sâu để giảm căng thẳng.\n",
            "\n",
            "6. **Theo dõi huyết áp thường xuyên:**\n",
            "   - Kiểm tra huyết áp thường xuyên để theo dõi tình trạng sức khỏe của bạn.\n",
            "\n",
            "7. **Tham khảo ý kiến bác sĩ:**\n",
            "   - Nếu các biện pháp trên không giúp giảm huyết áp, bạn nên tham khảo ý kiến bác sĩ để được tư vấn và có thể cần sử dụng thuốc hạ huyết áp.\n",
            "\n",
            "Bạn có thể cho tôi biết thêm về lối sống hiện tại của bạn hoặc bất kỳ triệu chứng nào khác mà bạn đang gặp phải để tôi có thể tư vấn cụ thể hơn không?\n",
            "Human: bạn nhớ huyết áp của tôi không?\n",
            "AI: Vâng, tôi nhớ huyết áp của bạn là 130/90 mmHg. Bạn có cần thêm thông tin hoặc tư vấn gì khác không?\n"
          ]
        }
      ],
      "source": [
        "print(chain.memory.buffer)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "collapsed": true,
        "id": "_1PkS_qWUdE5",
        "outputId": "2fff0b48-dfbd-4f25-83d4-8acbbd08ba6b"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Rosuvastatin\n",
            "\n",
            "Total Tokens: 102\n",
            "Prompt Tokens: 98\n",
            "Completion Tokens: 4\n",
            "Total Cost (USD): $0.00055\n",
            "Amlodipin, Valsartan, Hydrochlorothiazide\n",
            "\n",
            "Total Tokens: 107\n",
            "Prompt Tokens: 92\n",
            "Completion Tokens: 15\n",
            "Total Cost (USD): $0.0006850000000000001\n",
            "Metoprolol succinate\n",
            "\n",
            "Total Tokens: 81\n",
            "Prompt Tokens: 75\n",
            "Completion Tokens: 6\n",
            "Total Cost (USD): $0.000465\n",
            "Ubidecarenon\n",
            "\n",
            "Total Tokens: 62\n",
            "Prompt Tokens: 57\n",
            "Completion Tokens: 5\n",
            "Total Cost (USD): $0.00036\n",
            "Empagliflozin, Metformin hydroclorid\n",
            "\n",
            "Total Tokens: 81\n",
            "Prompt Tokens: 69\n",
            "Completion Tokens: 12\n",
            "Total Cost (USD): $0.0005250000000000001\n",
            "Amlodipine, Valsartan\n",
            "\n",
            "Total Tokens: 79\n",
            "Prompt Tokens: 70\n",
            "Completion Tokens: 9\n",
            "Total Cost (USD): $0.000485\n",
            "Metoprolol tartrate\n",
            "\n",
            "Total Tokens: 60\n",
            "Prompt Tokens: 54\n",
            "Completion Tokens: 6\n",
            "Total Cost (USD): $0.00035999999999999997\n",
            "Acid acetylsalicylic\n",
            "\n",
            "Total Tokens: 56\n",
            "Prompt Tokens: 49\n",
            "Completion Tokens: 7\n",
            "Total Cost (USD): $0.00035\n",
            "Metoprolol succinate\n",
            "\n",
            "Total Tokens: 81\n",
            "Prompt Tokens: 75\n",
            "Completion Tokens: 6\n",
            "Total Cost (USD): $0.000465\n"
          ]
        }
      ],
      "source": [
        "cost = 0\n",
        "for drug in Generic_drugs.keys():\n",
        "  with get_openai_callback() as cb:\n",
        "    output = chain.predict(patient_inf = drug)\n",
        "    print(output)\n",
        "    print()\n",
        "    print(f\"Total Tokens: {cb.total_tokens}\")\n",
        "    print(f\"Prompt Tokens: {cb.prompt_tokens}\")\n",
        "    print(f\"Completion Tokens: {cb.completion_tokens}\")\n",
        "    print(f\"Total Cost (USD): ${cb.total_cost}\")\n",
        "    cost += cb.total_cost"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 231
        },
        "id": "Ud5ran1no8dC",
        "outputId": "4adeb873-3a56-4d9e-dcfe-a23c169901a5"
      },
      "outputs": [
        {
          "ename": "NameError",
          "evalue": "name 'Generic_drugs' is not defined",
          "output_type": "error",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-50-0b4622b81537>\u001b[0m in \u001b[0;36m<cell line: 3>\u001b[0;34m()\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[0mdf\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mpd\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mDataFrame\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      2\u001b[0m \u001b[0mdf\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m'date'\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mdate_enc\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 3\u001b[0;31m \u001b[0;32mfor\u001b[0m \u001b[0mi\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mGeneric_drugs\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      4\u001b[0m   \u001b[0mdf\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mi\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mGeneric_drugs\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mi\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      5\u001b[0m \u001b[0mdf\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mdf\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mset_index\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'date'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mNameError\u001b[0m: name 'Generic_drugs' is not defined"
          ]
        }
      ],
      "source": [
        "df = pd.DataFrame()\n",
        "df['date'] = date_enc\n",
        "for i in Generic_drugs:\n",
        "  df[i] = Generic_drugs[i]\n",
        "df = df.set_index('date')\n",
        "df = df.reindex(sorted(df.columns), axis=1)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 509
        },
        "id": "_qysdNiRo_79",
        "outputId": "dcadd77f-8fde-4961-9079-2d0978aa88f8"
      },
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/seaborn/utils.py:61: UserWarning: Glyph 65293 (\\N{FULLWIDTH HYPHEN-MINUS}) missing from current font.\n",
            "  fig.canvas.draw()\n",
            "<ipython-input-10-dcde50908d9a>:3: UserWarning: Glyph 65293 (\\N{FULLWIDTH HYPHEN-MINUS}) missing from current font.\n",
            "  plt.savefig('/content/drive/MyDrive/NLP/drug_his.png')\n",
            "/usr/local/lib/python3.10/dist-packages/IPython/core/pylabtools.py:151: UserWarning: Glyph 65293 (\\N{FULLWIDTH HYPHEN-MINUS}) missing from current font.\n",
            "  fig.canvas.print_figure(bytes_io, **kw)\n"
          ]
        },
        {
          "data": {
            "image/png": "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",
            "text/plain": [
              "<Figure size 1500x1000 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "fig, ax = plt.subplots(1, 1, figsize=(15, 10))\n",
        "sns.heatmap(df.T,cmap=sns.light_palette('lightblue'),cbar = False)\n",
        "plt.savefig('/content/drive/MyDrive/NLP/drug_his.png')\n",
        "plt.show()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "BQg0bwGcsWrv",
        "outputId": "2b1d817b-1fa7-4e7a-de17-db4cafa2ebe9"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "dict_keys(['Crestor 10mg(Cơ sở đóng gói: AstraZeneca UK Limited, địa chỉ: Silk Road Business Park, Macclesfield, Cheshire, SK10 2NA, UK) － Rosuvastatin (dưới dạng Rosuvastatin calci) 10mg', 'Exforge HCT 5mg/160mg/12.5mg － Amlodipin (dưới dạng amlodipin besilate) 5mg; Valsartan 160mg; Hydrochlorothiazide 12,5mg', 'Betaloc Zok 25mg － Metoprolol succinat  23,75mg; (tương đương với Metoprolol tartrate 25mg)', 'Ticonet － Ubidecarenon (Coenzym Q10) 30mg', 'Jardiance Duo － Mỗi viên chứa: Empagliflozin 12,5mg; Metformin hydroclorid 1000mg', 'Exforge － Amlodipine (dưới dạng Amlodipine besylate) 5mg; Valsartan 80mg', 'Betaloc 50mg － Metoprolol tartrate 50mg', 'Aspilets EC － Acid acetylsalicylic', 'Betaloc Zok 50mg － Metoprolol succinat  47,5mg; (tương đương với Metoprolol tartrate 50mg)'])"
            ]
          },
          "execution_count": 20,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "Generic_drugs.keys()"
      ]
    }
  ],
  "metadata": {
    "colab": {
      "collapsed_sections": [
        "qixPaFyBxMlf"
      ],
      "provenance": []
    },
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}
